{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:00:36Z","timestamp":1780898436471,"version":"3.54.1"},"reference-count":295,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11154-026-10034-9","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:43:39Z","timestamp":1776753819000},"page":"645-669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From brain bioenergetics to hypothalamic glucoregulation: A shared-systems hypothesis for intrinsic dysglycemia in schizophrenia"],"prefix":"10.1007","volume":"27","author":[{"given":"Laurie","family":"Hamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameth N.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Mahavir","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony K. T.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"10034_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(15)01121-6.","journal-title":"Lancet"},{"key":"10034_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry Off J World Psychiatr Assoc. 2022;21:248\u201371. https:\/\/doi.org\/10.1002\/wps.20994.","journal-title":"World Psychiatry Off J World Psychiatr Assoc"},{"key":"10034_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","volume":"25","author":"TM Laursen","year":"2012","unstructured":"Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012;25:83\u20138. https:\/\/doi.org\/10.1097\/YCO.0b013e32835035ca.","journal-title":"Curr Opin Psychiatry"},{"key":"10034_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339\u201347. https:\/\/doi.org\/10.1002\/wps.20252.","journal-title":"World Psychiatry"},{"key":"10034_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2016.16040442","volume":"174","author":"AP Rajkumar","year":"2017","unstructured":"Rajkumar AP, Horsdal HT, Wimberley T, et al. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study. Am J Psychiatry. 2017;174:686\u201394. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16040442.","journal-title":"Am J Psychiatry"},{"key":"10034_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00164.2018","volume":"316","author":"C Kowalchuk","year":"2018","unstructured":"Kowalchuk C, Castellani LN, Chintoh A, et al. Antipsychotics and glucose metabolism: how brain and body collide. Am J Physiol Endocrinol Metab. 2018;316:E1\u201315. https:\/\/doi.org\/10.1152\/ajpendo.00164.2018.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10034_CR7","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/s41380-022-01798-y","volume":"27","author":"LN Castellani","year":"2022","unstructured":"Castellani LN, Pereira S, Kowalchuk C, et al. Antipsychotics impair regulation of glucose metabolism by central glucose. Mol Psychiatry. 2022;27:4741\u201353. https:\/\/doi.org\/10.1038\/s41380-022-01798-y.","journal-title":"Mol Psychiatry"},{"key":"10034_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamapsychiatry.2025.2240","volume":"82","author":"ECC Smith","year":"2025","unstructured":"Smith ECC, Agarwal SM, Panganiban KJ, et al. Antipsychotic Drugs and Dysregulated Glucose Homeostasis. JAMA Psychiatry. 2025;82:977\u201391. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.2240.","journal-title":"JAMA Psychiatry"},{"key":"10034_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00432","volume":"11","author":"Z Freyberg","year":"2017","unstructured":"Freyberg Z, Aslanoglou D, Shah R, Ballon JS. Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia. Front Neurosci. 2017;11:432. https:\/\/doi.org\/10.3389\/fnins.2017.00432.","journal-title":"Front Neurosci"},{"key":"10034_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","volume":"3","author":"BI Perry","year":"2016","unstructured":"Perry BI, McIntosh G, Weich S, et al. The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis. Lancet Psychiatry. 2016;3:1049\u201358. https:\/\/doi.org\/10.1016\/S2215-0366(16)30262-0.","journal-title":"Lancet Psychiatry"},{"key":"10034_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","volume":"74","author":"T Pillinger","year":"2017","unstructured":"Pillinger T, Beck K, Gobjila C, et al. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017;74:261\u20139. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.3803.","journal-title":"JAMA Psychiatry"},{"key":"10034_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.biopsych.2017.10.014","volume":"83","author":"CR Sullivan","year":"2018","unstructured":"Sullivan CR, O\u2019Donovan SM, McCullumsmith RE, Ramsey A. Defects in bioenergetic coupling in schizophrenia. Biol Psychiatry. 2018;83:739\u201350. https:\/\/doi.org\/10.1016\/j.biopsych.2017.10.014.","journal-title":"Biol Psychiatry"},{"key":"10034_CR13","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","volume":"27","author":"ND Henkel","year":"2022","unstructured":"Henkel ND, Wu X, O\u2019Donovan SM, et al. Schizophrenia: a disorder of broken brain bioenergetics. Mol Psychiatry. 2022;27:2393\u2013404. https:\/\/doi.org\/10.1038\/s41380-022-01494-x.","journal-title":"Mol Psychiatry"},{"key":"10034_CR14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.47.s64","author":"D Kohen","year":"2004","unstructured":"Kohen D. Diabetes mellitus and schizophrenia: Historical perspective. Br J Psychiatry. 2004. https:\/\/doi.org\/10.1192\/bjp.184.47.s64.","journal-title":"Br J Psychiatry"},{"key":"10034_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archneurpsyc.1926.02200280022002","volume":"16","author":"J Kasanin","year":"1926","unstructured":"Kasanin J. The blood sugar curve in mental disease: II. The schizophrenic (dementia praecox) groups. Arch Neurol Psychiatry. 1926;16:414\u20139. https:\/\/doi.org\/10.1001\/archneurpsyc.1926.02200280022002.","journal-title":"Arch Neurol Psychiatry"},{"key":"10034_CR16","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41380-018-0045-1","volume":"24","author":"V-A Chouinard","year":"2019","unstructured":"Chouinard V-A, Henderson DC, Dalla Man C, et al. Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis. Mol Psychiatry. 2019;24:1513\u201322. https:\/\/doi.org\/10.1038\/s41380-018-0045-1.","journal-title":"Mol Psychiatry"},{"key":"10034_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41398-018-0304-6","volume":"8","author":"S Hackinger","year":"2018","unstructured":"Hackinger S, Prins B, Mamakou V, et al. Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia. Transl Psychiatry. 2018;8:252. https:\/\/doi.org\/10.1038\/s41398-018-0304-6.","journal-title":"Transl Psychiatry"},{"key":"10034_CR18","doi-asserted-by":"publisher","first-page":"106049","DOI":"10.1016\/j.psyneuen.2023.106049","volume":"150","author":"C Aymerich","year":"2023","unstructured":"Aymerich C, Pedruzo B, Pacho M, et al. Prolactin and morning cortisol concentrations in antipsychotic na\u00efve first episode psychosis: A systematic review and meta-analysis. Psychoneuroendocrinology. 2023;150:106049. https:\/\/doi.org\/10.1016\/j.psyneuen.2023.106049.","journal-title":"Psychoneuroendocrinology"},{"key":"10034_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/mp.2015.87","volume":"21","author":"BS Fernandes","year":"2016","unstructured":"Fernandes BS, Steiner J, Bernstein H-G, et al. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry. 2016;21:554\u201364. https:\/\/doi.org\/10.1038\/mp.2015.87.","journal-title":"Mol Psychiatry"},{"key":"10034_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","volume":"71","author":"D Frydecka","year":"2018","unstructured":"Frydecka D, Krzystek-Korpacka M, Lubeiro A, et al. Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study. Brain Behav Immun. 2018;71:28\u201336. https:\/\/doi.org\/10.1016\/j.bbi.2018.05.002.","journal-title":"Brain Behav Immun"},{"key":"10034_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.schres.2016.03.018","volume":"174","author":"L Gonz\u00e1lez-Blanco","year":"2016","unstructured":"Gonz\u00e1lez-Blanco L, Greenhalgh AMD, Garcia-Rizo C, et al. Prolactin concentrations in antipsychotic-na\u00efve patients with schizophrenia and related disorders: A meta-analysis. Schizophr Res. 2016;174:156\u201360. https:\/\/doi.org\/10.1016\/j.schres.2016.03.018.","journal-title":"Schizophr Res"},{"key":"10034_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.psyneuen.2019.03.014","volume":"104","author":"DB Hubbard","year":"2019","unstructured":"Hubbard DB, Miller BJ. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology. 2019;104:269\u201375. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.03.014.","journal-title":"Psychoneuroendocrinology"},{"key":"10034_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663\u201371. https:\/\/doi.org\/10.1016\/j.biopsych.2011.04.013.","journal-title":"Biol Psychiatry"},{"key":"10034_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.schres.2019.03.012","volume":"226","author":"S Park","year":"2020","unstructured":"Park S, Miller BJ. Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. Schizophr Res. 2020;226:5\u201312. https:\/\/doi.org\/10.1016\/j.schres.2019.03.012.","journal-title":"Schizophr Res"},{"key":"10034_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116220","volume":"342","author":"Z Sarnyai","year":"2024","unstructured":"Sarnyai Z, Ben-Shachar D. Schizophrenia, a disease of impaired dynamic metabolic flexibility: a new mechanistic framework. Psychiatry Res. 2024;342:116220. https:\/\/doi.org\/10.1016\/j.psychres.2024.116220.","journal-title":"Psychiatry Res"},{"key":"10034_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.biopsych.2017.08.017","volume":"83","author":"R Hilker","year":"2018","unstructured":"Hilker R, Helenius D, Fagerlund B, et al. Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish twin register. Biol Psychiatry. 2018;83:492\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2017.08.017.","journal-title":"Biol Psychiatry"},{"key":"10034_CR27","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","volume":"60","author":"PF Sullivan","year":"2003","unstructured":"Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187\u201392. https:\/\/doi.org\/10.1001\/archpsyc.60.12.1187.","journal-title":"Arch Gen Psychiatry"},{"key":"10034_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138. https:\/\/doi.org\/10.1038\/s41586-022-04434-5.","journal-title":"Nature"},{"key":"10034_CR29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","volume":"168","author":"ME Benros","year":"2011","unstructured":"Benros ME, Nielsen PR, Nordentoft M, et al. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011;168:1303\u201310. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11030516.","journal-title":"Am J Psychiatry"},{"key":"10034_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","volume":"81","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Owen MJ, Murray RM. The role of genes, stress, and dopamine in the development of schizophrenia. Biol Psychiatry. 2017;81:9\u201320. https:\/\/doi.org\/10.1016\/j.biopsych.2016.07.014.","journal-title":"Biol Psychiatry"},{"key":"10034_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, et al. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71:1121\u20138. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1332.","journal-title":"JAMA Psychiatry"},{"key":"10034_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03621-1","volume":"9","author":"AN Barbeira","year":"2018","unstructured":"Barbeira AN, Dickinson SP, Bonazzola R, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825. https:\/\/doi.org\/10.1038\/s41467-018-03621-1.","journal-title":"Nat Commun"},{"key":"10034_CR33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41380-021-01420-7","volume":"27","author":"AK Merikangas","year":"2022","unstructured":"Merikangas AK, Shelly M, Knighton A, et al. What genes are differentially expressed in individuals with schizophrenia? A systematic review. Mol Psychiatry. 2022;27:1373\u201383. https:\/\/doi.org\/10.1038\/s41380-021-01420-7.","journal-title":"Mol Psychiatry"},{"key":"10034_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-025-00670-6","volume":"11","author":"Y Xie","year":"2025","unstructured":"Xie Y, Du J, Zhao Z, et al. The shared genetic architecture between schizophrenia and common peripheral organ imaging phenotypes. Schizophr. 2025;11:122. https:\/\/doi.org\/10.1038\/s41537-025-00670-6.","journal-title":"Schizophr"},{"key":"10034_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41380-018-0058-9","volume":"24","author":"T Pillinger","year":"2019","unstructured":"Pillinger T, D\u2019Ambrosio E, McCutcheon R, Howes OD. Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. Mol Psychiatry. 2019;24:776\u201394. https:\/\/doi.org\/10.1038\/s41380-018-0058-9.","journal-title":"Mol Psychiatry"},{"key":"10034_CR36","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1152\/ajpregu.1981.241.3.r203","volume":"241","author":"JW Mink","year":"1981","unstructured":"Mink JW, Blumenschine RJ, Adams DB. Ratio of central nervous system to body metabolism in vertebrates: its constancy and functional basis. Am J Physiol Regul Integr Comp Physiol. 1981;241:R203-12. https:\/\/doi.org\/10.1152\/ajpregu.1981.241.3.r203.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10034_CR37","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21:1133\u201345. https:\/\/doi.org\/10.1097\/00004647-200110000-00001.","journal-title":"J Cereb Blood Flow Metab"},{"key":"10034_CR38","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","volume":"75","author":"JJ Harris","year":"2012","unstructured":"Harris JJ, Jolivet R, Attwell D. Synaptic energy use and supply. Neuron. 2012;75:762\u201377. https:\/\/doi.org\/10.1016\/j.neuron.2012.08.019.","journal-title":"Neuron"},{"key":"10034_CR39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M B\u00e9langer","year":"2011","unstructured":"B\u00e9langer M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724\u201338. https:\/\/doi.org\/10.1016\/j.cmet.2011.08.016.","journal-title":"Cell Metab"},{"key":"10034_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","volume":"19","author":"PJ Magistretti","year":"2018","unstructured":"Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19:235\u201349. https:\/\/doi.org\/10.1038\/nrn.2018.19.","journal-title":"Nat Rev Neurosci"},{"key":"10034_CR41","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA. 1994;91:10625\u20139. https:\/\/doi.org\/10.1073\/pnas.91.22.10625.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10034_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03168.x","volume":"94","author":"K Pierre","year":"2005","unstructured":"Pierre K, Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem. 2005;94:1\u201314. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03168.x.","journal-title":"J Neurochem"},{"issue":"1","key":"10034_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7807","volume":"6","author":"I Lundgaard","year":"2015","unstructured":"Lundgaard I, Li B, Xie L, et al. Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. Nature Communications. 2015;6807. https:\/\/doi.org\/10.1038\/ncomms7807.","journal-title":"Nature Communications"},{"key":"10034_CR44","doi-asserted-by":"publisher","first-page":"154869","DOI":"10.1016\/j.metabol.2021.154869","volume":"123","author":"W Peng","year":"2021","unstructured":"Peng W, Tan C, Mo L, et al. Glucose transporter 3 in neuronal glucose metabolism: Health and diseases. Metabolism. 2021;123:154869. https:\/\/doi.org\/10.1016\/j.metabol.2021.154869.","journal-title":"Metabolism"},{"key":"10034_CR45","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1523\/jneurosci.1850-09.2011","volume":"31","author":"JM Ferreira","year":"2011","unstructured":"Ferreira JM, Burnett AL, Rameau GA. Activity-dependent regulation of surface glucose transporter-3. J Neurosci. 2011;31:1991\u20139. https:\/\/doi.org\/10.1523\/jneurosci.1850-09.2011.","journal-title":"J Neurosci"},{"key":"10034_CR46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ncb1881","volume":"11","author":"A Herrero-Mendez","year":"2009","unstructured":"Herrero-Mendez A, Almeida A, Fern\u00e1ndez E, et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C\u2013Cdh1. Nat Cell Biol. 2009;11:747\u201352. https:\/\/doi.org\/10.1038\/ncb1881.","journal-title":"Nat Cell Biol"},{"key":"10034_CR47","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/s42255-024-01049-0","volume":"6","author":"D Jimenez-Blasco","year":"2024","unstructured":"Jimenez-Blasco D, Agulla J, Lapresa R, et al. Weak neuronal glycolysis sustains cognition and organismal fitness. Nat Metab. 2024;6:1253\u201367. https:\/\/doi.org\/10.1038\/s42255-024-01049-0.","journal-title":"Nat Metab"},{"key":"10034_CR48","doi-asserted-by":"publisher","unstructured":"Bola\u00f1os JP, Magistretti PJ. The neuron-astrocyte metabolic unit as a cornerstone of brain energy metabolism in health and disease. Nat Metab. 2025;1\u201310. https:\/\/doi.org\/10.1038\/s42255-025-01404-9.","DOI":"10.1038\/s42255-025-01404-9"},{"key":"10034_CR49","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.3390\/ijms22126568","volume":"22","author":"S Takahashi","year":"2021","unstructured":"Takahashi S. Neuroprotective function of high glycolytic activity in astrocytes: common roles in stroke and neurodegenerative diseases. Int J Mol Sci. 2021;22:6568. https:\/\/doi.org\/10.3390\/ijms22126568.","journal-title":"Int J Mol Sci"},{"key":"10034_CR50","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1073\/pnas.101129298","volume":"98","author":"RG Shulman","year":"2001","unstructured":"Shulman RG, Hyder F, Rothman DL. Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc Natl Acad Sci. 2001;98:6417\u201322. https:\/\/doi.org\/10.1073\/pnas.101129298.","journal-title":"Proc Natl Acad Sci"},{"key":"10034_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1471-4159.2004.02421.x","volume":"89","author":"AM Brown","year":"2004","unstructured":"Brown AM. Brain glycogen re-awakened. J Neurochem. 2004;89:537\u201352. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02421.x.","journal-title":"J Neurochem"},{"key":"10034_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0495-2","volume":"2","author":"G Descalzi","year":"2019","unstructured":"Descalzi G, Gao V, Steinman MQ, et al. Lactate from astrocytes fuels learning-induced mRNA translation in excitatory and inhibitory neurons. Commun Biol. 2019;2:247. https:\/\/doi.org\/10.1038\/s42003-019-0495-2.","journal-title":"Commun Biol"},{"key":"10034_CR53","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","volume":"144","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Stern SA, Bozdagi O, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 2011;144:810\u201323. https:\/\/doi.org\/10.1016\/j.cell.2011.02.018.","journal-title":"Cell"},{"key":"10034_CR54","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0568","author":"A Kleinridders","year":"2014","unstructured":"Kleinridders A, Ferris HA, Cai W, Kahn RC. Insulin Action in Brain Regulates Systemic Metabolism and Brain Function. Diabetes. 2014. https:\/\/doi.org\/10.2337\/db14-0568.","journal-title":"Diabetes"},{"key":"10034_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101234","volume":"52","author":"JL Milstein","year":"2021","unstructured":"Milstein JL, Ferris HA. The brain as an insulin-sensitive metabolic organ. Mol Metab. 2021;52:101234. https:\/\/doi.org\/10.1016\/j.molmet.2021.101234.","journal-title":"Mol Metab"},{"key":"10034_CR56","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/s0196-9781(97)00231-3","volume":"18","author":"WA Banks","year":"1997","unstructured":"Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides. 1997;18:1423\u20139. https:\/\/doi.org\/10.1016\/s0196-9781(97)00231-3.","journal-title":"Peptides"},{"key":"10034_CR57","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/272827a0","volume":"272","author":"J Havrankova","year":"1978","unstructured":"Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272:827\u20139. https:\/\/doi.org\/10.1038\/272827a0.","journal-title":"Nature"},{"key":"10034_CR58","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","volume":"166","author":"C Garc\u00eda-C\u00e1ceres","year":"2016","unstructured":"Garc\u00eda-C\u00e1ceres C, Quarta C, Varela L, et al. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell. 2016;166:867\u201380. https:\/\/doi.org\/10.1016\/j.cell.2016.07.028.","journal-title":"Cell"},{"key":"10034_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2337\/db16-0861","volume":"66","author":"AM Fernandez","year":"2017","unstructured":"Fernandez AM, Hernandez-Garz\u00f3n E, Perez-Domper P, et al. Insulin Regulates Astrocytic Glucose Handling Through Cooperation With IGF-I. Diabetes. 2017;66:64\u201374. https:\/\/doi.org\/10.2337\/db16-0861.","journal-title":"Diabetes"},{"key":"10034_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021594","volume":"6","author":"M Heni","year":"2011","unstructured":"Heni M, Hennige AM, Peter A, et al. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS ONE. 2011;6:e21594. https:\/\/doi.org\/10.1371\/journal.pone.0021594.","journal-title":"PLoS ONE"},{"key":"10034_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0006-8993(98)00103-6","volume":"797","author":"SJ Vannucci","year":"1998","unstructured":"Vannucci SJ, Koehler-Stec EM, Li K, et al. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res. 1998;797:1\u201311. https:\/\/doi.org\/10.1016\/s0006-8993(98)00103-6.","journal-title":"Brain Res"},{"key":"10034_CR62","doi-asserted-by":"crossref","unstructured":"Apelt J, Mehlhorn G, Schliebs R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3\u2010expressing cells and demonstrate a chemically distinct neuron\u2010specific localization in rat brain. J Neurosci Res. 1999;57:693\u2013705. https:\/\/doi.org\/10.1002\/(sici)1097-4547(19990901)57:5%253C693::aid-jnr11%253E3.0.co;2-x.","DOI":"10.1002\/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X"},{"key":"10034_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.brainres.2009.08.005","volume":"1296","author":"C Grillo","year":"2009","unstructured":"Grillo C, Piroli G, Hendry R, Reagan L. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 2009;1296:35\u201345. https:\/\/doi.org\/10.1016\/j.brainres.2009.08.005.","journal-title":"Brain Res"},{"key":"10034_CR64","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuron.2016.12.020","volume":"93","author":"G Ashrafi","year":"2017","unstructured":"Ashrafi G, Wu Z, Farrell RJ, Ryan TA. GLUT4 mobilization supports energetic demands of active synapses. Neuron. 2017;93:606-615.e3. https:\/\/doi.org\/10.1016\/j.neuron.2016.12.020.","journal-title":"Neuron"},{"key":"10034_CR65","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1073\/pnas.051634698","volume":"98","author":"VA Skeberdis","year":"2001","unstructured":"Skeberdis VA, Lan J, Zheng X, et al. Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci. 2001;98:3561\u20136. https:\/\/doi.org\/10.1073\/pnas.051634698.","journal-title":"Proc Natl Acad Sci"},{"key":"10034_CR66","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s0896-6273(00)81067-3","volume":"25","author":"H-Y Man","year":"2000","unstructured":"Man H-Y, Lin JW, Ju WH, et al. Regulation of AMPA receptor\u2013mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron. 2000;25:649\u201362. https:\/\/doi.org\/10.1016\/s0896-6273(00)81067-3.","journal-title":"Neuron"},{"key":"10034_CR67","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/81823","volume":"3","author":"EC Beattie","year":"2000","unstructured":"Beattie EC, Carroll RC, Yu X, et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci. 2000;3:1291\u2013300. https:\/\/doi.org\/10.1038\/81823.","journal-title":"Nat Neurosci"},{"key":"10034_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00047","volume":"9","author":"O Kann","year":"2016","unstructured":"Kann O, Hollnagel J-O, Elzoheiry S, Schneider J. Energy and potassium ion homeostasis during gamma oscillations. Front Mol Neurosci. 2016;9:47. https:\/\/doi.org\/10.3389\/fnmol.2016.00047.","journal-title":"Front Mol Neurosci"},{"key":"10034_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220937","volume":"14","author":"DS Tourigny","year":"2019","unstructured":"Tourigny DS, Karim MKA, Echeveste R, et al. Energetic substrate availability regulates synchronous activity in an excitatory neural network. PLoS One. 2019;14:e0220937. https:\/\/doi.org\/10.1371\/journal.pone.0220937.","journal-title":"PLoS One"},{"key":"10034_CR70","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrn2774","volume":"11","author":"PJ Uhlhaas","year":"2010","unstructured":"Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010;11:100\u201313. https:\/\/doi.org\/10.1038\/nrn2774.","journal-title":"Nat Rev Neurosci"},{"key":"10034_CR71","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1017\/S003329172200174X","volume":"53","author":"L Townsend","year":"2023","unstructured":"Townsend L, Pillinger T, Selvaggi P, et al. Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18FDG-PET studies in schizophrenia. Psychol Med. 2023;53:4880\u201397. https:\/\/doi.org\/10.1017\/S003329172200174X.","journal-title":"Psychol Med"},{"key":"10034_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0920-9964(99)00178-4","volume":"43","author":"EA Hazlett","year":"2000","unstructured":"Hazlett EA, Buchsbaum MS, Jeu LA, et al. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr Res. 2000;43:33\u201346. https:\/\/doi.org\/10.1016\/s0920-9964(99)00178-4.","journal-title":"Schizophr Res"},{"key":"10034_CR73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2020.09.003","volume":"223","author":"BS Pruett","year":"2020","unstructured":"Pruett BS, Meador-Woodruff JH. Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies. Schizophr Res. 2020;223:29\u201342. https:\/\/doi.org\/10.1016\/j.schres.2020.09.003.","journal-title":"Schizophr Res"},{"key":"10034_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2023.11.013","volume":"264","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang L, Fan X, et al. Lactate levels in the brain and blood of schizophrenia patients: A systematic review and meta-analysis. Schizophr Res. 2024;264:29\u201338. https:\/\/doi.org\/10.1016\/j.schres.2023.11.013.","journal-title":"Schizophr Res"},{"key":"10034_CR75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jneumeth.2007.11.017","volume":"169","author":"ND Halim","year":"2008","unstructured":"Halim ND, Lipska BK, Hyde TM, et al. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. J Neurosci Methods. 2008;169:208\u201313. https:\/\/doi.org\/10.1016\/j.jneumeth.2007.11.017.","journal-title":"J Neurosci Methods"},{"key":"10034_CR76","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1038\/tp.2016.239","volume":"6","author":"LM Rowland","year":"2016","unstructured":"Rowland LM, Pradhan S, Korenic S, et al. Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study. Transl Psychiatry. 2016;6:e967\u2013967. https:\/\/doi.org\/10.1038\/tp.2016.239.","journal-title":"Transl Psychiatry"},{"key":"10034_CR77","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.biopsych.2008.11.010","volume":"65","author":"WT Regenold","year":"2009","unstructured":"Regenold WT, Phatak P, Marano CM, et al. Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis. Biol Psychiatry. 2009;65:489\u201394. https:\/\/doi.org\/10.1016\/j.biopsych.2008.11.010.","journal-title":"Biol Psychiatry"},{"key":"10034_CR78","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41380-018-0035-3","volume":"24","author":"CR Sullivan","year":"2019","unstructured":"Sullivan CR, Koene RH, Hasselfeld K, et al. Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry. 2019;24:1319\u201328. https:\/\/doi.org\/10.1038\/s41380-018-0035-3.","journal-title":"Mol Psychiatry"},{"key":"10034_CR79","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbi.2020.07.043","volume":"91","author":"SG Lago","year":"2021","unstructured":"Lago SG, Tomasik J, van Rees GF, et al. Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain Behav Immun. 2021;91:673\u201382. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.043.","journal-title":"Brain Behav Immun"},{"key":"10034_CR80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41398-022-02229-w","volume":"12","author":"JK Zaki","year":"2022","unstructured":"Zaki JK, Lago SG, Rustogi N, et al. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Transl Psychiatry. 2022;12:457. https:\/\/doi.org\/10.1038\/s41398-022-02229-w.","journal-title":"Transl Psychiatry"},{"key":"10034_CR81","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/mp.2010.71","volume":"16","author":"M Herberth","year":"2011","unstructured":"Herberth M, Koethe D, Cheng TMK, et al. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Mol Psychiatry. 2011;16:848\u201359. https:\/\/doi.org\/10.1038\/mp.2010.71.","journal-title":"Mol Psychiatry"},{"key":"10034_CR82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.20132","volume":"127B","author":"WS Stone","year":"2004","unstructured":"Stone WS, Faraone SV, Su J, et al. Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. Am J Med Genet B Neuropsychiatr Genet. 2004;127B:5\u201310. https:\/\/doi.org\/10.1002\/ajmg.b.20132.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10034_CR83","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.neuropharm.2010.12.027","volume":"62","author":"NJ Bradshaw","year":"2012","unstructured":"Bradshaw NJ, Porteous DJ. DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology. 2012;62:1230\u201341. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.12.027.","journal-title":"Neuropharmacology"},{"key":"10034_CR84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.schres.2016.12.027","volume":"187","author":"LC Murphy","year":"2017","unstructured":"Murphy LC, Millar JK. Regulation of mitochondrial dynamics by DISC1, a putative risk factor for major mental illness. Schizophr Res. 2017;187:55\u201361. https:\/\/doi.org\/10.1016\/j.schres.2016.12.027.","journal-title":"Schizophr Res"},{"key":"10034_CR85","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1093\/hmg\/ddw250","volume":"25","author":"E Pi\u00f1ero-Martos","year":"2016","unstructured":"Pi\u00f1ero-Martos E, Ortega-Vila B, Pol-Fuster J, et al. Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative phosphorylation. Hum Mol Genet. 2016;25:4157\u201369. https:\/\/doi.org\/10.1093\/hmg\/ddw250.","journal-title":"Hum Mol Genet"},{"key":"10034_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0123-9","volume":"8","author":"Y Jouroukhin","year":"2018","unstructured":"Jouroukhin Y, Kageyama Y, Misheneva V, et al. DISC1 regulates lactate metabolism in astrocytes: implications for psychiatric disorders. Transl Psychiatry. 2018;8:76. https:\/\/doi.org\/10.1038\/s41398-018-0123-9.","journal-title":"Transl Psychiatry"},{"key":"10034_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.schres.2016.04.024","volume":"177","author":"R Pinacho","year":"2016","unstructured":"Pinacho R, Vila E, Prades R, et al. The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia. Schizophr Res. 2016;177:37\u201343. https:\/\/doi.org\/10.1016\/j.schres.2016.04.024.","journal-title":"Schizophr Res"},{"key":"10034_CR88","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.1112085","volume":"309","author":"TKT Lam","year":"2005","unstructured":"Lam TKT, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science. 2005;309:943\u20137. https:\/\/doi.org\/10.1126\/science.1112085.","journal-title":"Science"},{"key":"10034_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101011","volume":"39","author":"RJW Li","year":"2020","unstructured":"Li RJW, Zhang S-Y, Lam TKT. Interaction of glucose sensing and leptin action in the brain. Mol Metab. 2020;39:101011. https:\/\/doi.org\/10.1016\/j.molmet.2020.101011.","journal-title":"Mol Metab"},{"key":"10034_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2018.11.001","volume":"29","author":"MA Bentsen","year":"2019","unstructured":"Bentsen MA, Mirzadeh Z, Schwartz MW. Revisiting how the brain senses glucose-and why. Cell Metab. 2019;29:11\u20137. https:\/\/doi.org\/10.1016\/j.cmet.2018.11.001.","journal-title":"Cell Metab"},{"key":"10034_CR91","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00125-021-05395-6","volume":"64","author":"NA Yoon","year":"2021","unstructured":"Yoon NA, Diano S. Hypothalamic glucose-sensing mechanisms. Diabetologia. 2021;64:985\u201393. https:\/\/doi.org\/10.1007\/s00125-021-05395-6.","journal-title":"Diabetologia"},{"key":"10034_CR92","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2337\/db11-0120","volume":"60","author":"M Chari","year":"2011","unstructured":"Chari M, Yang CS, Lam CKL, et al. Glucose transporter-1 in the hypothalamic glial cells mediates glucose sensing to regulate glucose production in vivo. Diabetes. 2011;60:1901\u20136. https:\/\/doi.org\/10.2337\/db11-0120.","journal-title":"Diabetes"},{"key":"10034_CR93","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1074\/jbc.RA117.000838","volume":"293","author":"MA Abraham","year":"2018","unstructured":"Abraham MA, Rasti M, Bauer PV, Lam TKT. Leptin enhances hypothalamic lactate dehydrogenase A (LDHA)-dependent glucose sensing to lower glucose production in high-fat-fed rats. J Biol Chem. 2018;293:4159\u201366. https:\/\/doi.org\/10.1074\/jbc.RA117.000838.","journal-title":"J Biol Chem"},{"key":"10034_CR94","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.semcdb.2023.07.010","volume":"156","author":"D Borgmann","year":"2024","unstructured":"Borgmann D, Fenselau H. Vagal pathways for systemic regulation of glucose metabolism. Semin Cell Dev Biol. 2024;156:244\u201352. https:\/\/doi.org\/10.1016\/j.semcdb.2023.07.010.","journal-title":"Semin Cell Dev Biol"},{"key":"10034_CR95","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2337\/db10-0994","volume":"60","author":"CKL Lam","year":"2011","unstructured":"Lam CKL, Chari M, Rutter GA, Lam TKT. Hypothalamic nutrient sensing activates a forebrain-hindbrain neuronal circuit to regulate glucose production in vivo. Diabetes. 2011;60:107\u201313. https:\/\/doi.org\/10.2337\/db10-0994.","journal-title":"Diabetes"},{"key":"10034_CR96","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature03439","volume":"434","author":"A Pocai","year":"2005","unstructured":"Pocai A, Lam TKT, Gutierrez-Juarez R, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature. 2005;434:1026\u201331. https:\/\/doi.org\/10.1038\/nature03439.","journal-title":"Nature"},{"key":"10034_CR97","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm1201","volume":"11","author":"TKT Lam","year":"2005","unstructured":"Lam TKT, Pocai A, Gutierrez-Juarez R, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med. 2005;11:320\u20137. https:\/\/doi.org\/10.1038\/nm1201.","journal-title":"Nat Med"},{"key":"10034_CR98","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.2337\/dbi24-0001","volume":"73","author":"Z Mirzadeh","year":"2024","unstructured":"Mirzadeh Z, Faber C. Brain defense of glycemia in health and diabetes. Diabetes. 2024;73:1952\u201366. https:\/\/doi.org\/10.2337\/dbi24-0001.","journal-title":"Diabetes"},{"key":"10034_CR99","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2337\/diabetes.53.3.549","volume":"53","author":"L Kang","year":"2004","unstructured":"Kang L, Routh VH, Kuzhikandathil EV, et al. Physiological and Molecular Characteristics of Rat Hypothalamic Ventromedial Nucleus Glucosensing Neurons. Diabetes. 2004;53:549\u201359. https:\/\/doi.org\/10.2337\/diabetes.53.3.549.","journal-title":"Diabetes"},{"key":"10034_CR100","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/BF00373626","volume":"415","author":"MLJ Ashford","year":"1990","unstructured":"Ashford MLJ, Boden PR, Treherne JM. Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflugers Arch Eur J Physiol. 1990;415:479\u201383. https:\/\/doi.org\/10.1007\/BF00373626.","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"10034_CR101","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/87455","volume":"4","author":"T Miki","year":"2001","unstructured":"Miki T, Liss B, Minami K, et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci. 2001;4:507\u201312. https:\/\/doi.org\/10.1038\/87455.","journal-title":"Nat Neurosci"},{"key":"10034_CR102","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2337\/diabetes.53.8.1953","volume":"53","author":"RJ McCrimmon","year":"2004","unstructured":"McCrimmon RJ, Fan X, Ding Y, et al. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes. 2004;53:1953\u20138. https:\/\/doi.org\/10.2337\/diabetes.53.8.1953.","journal-title":"Diabetes"},{"key":"10034_CR103","doi-asserted-by":"publisher","first-page":"C750","DOI":"10.1152\/ajpcell.00127.2009","volume":"297","author":"BA Murphy","year":"2009","unstructured":"Murphy BA, Fakira KA, Song Z, et al. AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. Am J Physiol Cell Physiol. 2009;297:C750-758. https:\/\/doi.org\/10.1152\/ajpcell.00127.2009.","journal-title":"Am J Physiol Cell Physiol"},{"key":"10034_CR104","doi-asserted-by":"publisher","first-page":"e163391","DOI":"10.1172\/JCI163391","volume":"133","author":"L Tu","year":"2023","unstructured":"Tu L, Bean JC, He Y, et al. Anoctamin 4 channel currents activate glucose-inhibited neurons in the mouse ventromedial hypothalamus during hypoglycemia. J Clin Invest. 2023;133:e163391. https:\/\/doi.org\/10.1172\/JCI163391.","journal-title":"J Clin Invest"},{"key":"10034_CR105","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cmet.2017.01.003","volume":"25","author":"A Santoro","year":"2017","unstructured":"Santoro A, Campolo M, Liu C, et al. DRP1 Suppresses Leptin and Glucose Sensing of POMC Neurons. Cell Metab. 2017;25:647\u201360. https:\/\/doi.org\/10.1016\/j.cmet.2017.01.003.","journal-title":"Cell Metab"},{"key":"10034_CR106","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2017.05.010","volume":"25","author":"S Ram\u00edrez","year":"2017","unstructured":"Ram\u00edrez S, G\u00f3mez-Valad\u00e9s AG, Schneeberger M, et al. Mitochondrial dynamics mediated by mitofusin 1 is required for POMC neuron glucose-sensing and insulin release control. Cell Metab. 2017;25:1390-1399.e6. https:\/\/doi.org\/10.1016\/j.cmet.2017.05.010.","journal-title":"Cell Metab"},{"key":"10034_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15259","volume":"8","author":"J Ruud","year":"2017","unstructured":"Ruud J, Steculorum SM, Br\u00fcning JC. Neuronal control of peripheral insulin sensitivity and glucose metabolism. Nat Commun. 2017;8:15259. https:\/\/doi.org\/10.1038\/ncomms15259.","journal-title":"Nat Commun"},{"key":"10034_CR108","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","volume":"33","author":"J Olney","year":"1999","unstructured":"Olney J, Newcomer J, Farber N. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999;33:523\u201333.","journal-title":"J Psychiatr Res"},{"key":"10034_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","volume":"37","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37:4\u201315. https:\/\/doi.org\/10.1038\/npp.2011.181.","journal-title":"Neuropsychopharmacology"},{"key":"10034_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107426","volume":"205","author":"K Nakazawa","year":"2020","unstructured":"Nakazawa K, Sapkota K. The origin of NMDA receptor hypofunction in schizophrenia. Pharmacol Ther. 2020;205:107426. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107426.","journal-title":"Pharmacol Ther"},{"key":"10034_CR111","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62:405\u201396. https:\/\/doi.org\/10.1124\/pr.109.002451.","journal-title":"Pharmacol Rev"},{"key":"10034_CR112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199\u2013214. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950030035004.","journal-title":"Arch Gen Psychiatry"},{"key":"10034_CR113","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/pl00000638","volume":"57","author":"Y-B Choi","year":"2000","unstructured":"Choi Y-B, Lipton SA. Redox modulation of the NMDA receptor. Cell Mol Life Sci. 2000;57:1535\u201341. https:\/\/doi.org\/10.1007\/pl00000638.","journal-title":"Cell Mol Life Sci"},{"key":"10034_CR114","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nn2071","volume":"11","author":"S Papadia","year":"2008","unstructured":"Papadia S, Soriano FX, L\u00e9veill\u00e9 F, et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci. 2008;11:476\u201387. https:\/\/doi.org\/10.1038\/nn2071.","journal-title":"Nat Neurosci"},{"key":"10034_CR115","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1523\/jneurosci.2213-07.2007","volume":"27","author":"H Homayoun","year":"2007","unstructured":"Homayoun H, Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci. 2007;27:11496\u2013500. https:\/\/doi.org\/10.1523\/jneurosci.2213-07.2007.","journal-title":"J Neurosci"},{"key":"10034_CR116","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/schbul\/sbs010","volume":"38","author":"G Gonzalez-Burgos","year":"2012","unstructured":"Gonzalez-Burgos G, Lewis DA. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull. 2012;38:950\u20137. https:\/\/doi.org\/10.1093\/schbul\/sbs010.","journal-title":"Schizophr Bull"},{"key":"10034_CR117","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/schbul\/sbn176","volume":"35","author":"KE Stephan","year":"2009","unstructured":"Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull. 2009;35:509\u201327. https:\/\/doi.org\/10.1093\/schbul\/sbn176.","journal-title":"Schizophr Bull"},{"key":"10034_CR118","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci Off J Soc Neurosci. 1997;17:2921\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-08-02921.1997.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10034_CR119","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nn.2447","volume":"13","author":"JE Belforte","year":"2010","unstructured":"Belforte JE, Zsiros V, Sklar ER, et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci. 2010;13:76\u201383. https:\/\/doi.org\/10.1038\/nn.2447.","journal-title":"Nat Neurosci"},{"key":"10034_CR120","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2016.04.004","volume":"93","author":"M Inan","year":"2016","unstructured":"Inan M, Zhao M, Manuszak M, et al. Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability. Neurobiol Dis. 2016;93:35\u201346. https:\/\/doi.org\/10.1016\/j.nbd.2016.04.004.","journal-title":"Neurobiol Dis"},{"key":"10034_CR121","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neuron.2007.11.008","volume":"56","author":"G Buzs\u00e1ki","year":"2007","unstructured":"Buzs\u00e1ki G, Kaila K, Raichle M. Inhibition and brain work. Neuron. 2007;56:771\u201383. https:\/\/doi.org\/10.1016\/j.neuron.2007.11.008.","journal-title":"Neuron"},{"key":"10034_CR122","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuro.2022.02.005","volume":"90","author":"D Kolar","year":"2022","unstructured":"Kolar D, Kleteckova L, Skalova K, et al. Glycolytic and Krebs cycle enzymes activity in rat prefrontal cortex, hippocampus, and striatum after single and repeated NMDA inhibition by MK-801. NeuroToxicology. 2022;90:35\u201347. https:\/\/doi.org\/10.1016\/j.neuro.2022.02.005.","journal-title":"NeuroToxicology"},{"key":"10034_CR123","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/schbul\/sbq132","volume":"38","author":"K Zhou","year":"2012","unstructured":"Zhou K, Yang Y, Gao L, et al. NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism And Semaphorin Signaling in Rats: A Synaptic Proteome Study. Schizophr Bull. 2012;38:579\u201391. https:\/\/doi.org\/10.1093\/schbul\/sbq132.","journal-title":"Schizophr Bull"},{"key":"10034_CR124","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/s41380-021-01374-w","volume":"27","author":"M Cuenod","year":"2022","unstructured":"Cuenod M, Steullet P, Cabungcal J-H, et al. Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia. Mol Psychiatry. 2022;27:1886\u201397. https:\/\/doi.org\/10.1038\/s41380-021-01374-w.","journal-title":"Mol Psychiatry"},{"key":"10034_CR125","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/mp.2017.47","volume":"22","author":"P Steullet","year":"2017","unstructured":"Steullet P, Cabungcal J-H, Coyle J, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry. 2017;22:936\u201343. https:\/\/doi.org\/10.1038\/mp.2017.47.","journal-title":"Mol Psychiatry"},{"key":"10034_CR126","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","volume":"29","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Engberg G, Shimizu E, et al. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:767\u20139. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.04.023.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10034_CR127","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","volume":"90","author":"I Bendikov","year":"2007","unstructured":"Bendikov I, Nadri C, Amar S, et al. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr Res. 2007;90:41\u201351. https:\/\/doi.org\/10.1016\/j.schres.2006.10.010.","journal-title":"Schizophr Res"},{"key":"10034_CR128","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.euroneuro.2007.12.002","volume":"18","author":"SA Fuchs","year":"2008","unstructured":"Fuchs SA, Barse MMJD, Scheepers FE, et al. Cerebrospinal fluid d-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. Eur Neuropsychopharmacol. 2008;18:333\u20138. https:\/\/doi.org\/10.1016\/j.euroneuro.2007.12.002.","journal-title":"Eur Neuropsychopharmacol"},{"key":"10034_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244x-5-6","volume":"5","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Engberg G, Shimizu E, et al. Elevated glutamine\/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry. 2005;5:6. https:\/\/doi.org\/10.1186\/1471-244x-5-6.","journal-title":"BMC Psychiatry"},{"key":"10034_CR130","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","volume":"159","author":"J Theberge","year":"2002","unstructured":"Theberge J, Bartha R, Drost DJ, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry. 2002;159:1944\u20136. https:\/\/doi.org\/10.1176\/appi.ajp.159.11.1944.","journal-title":"Am J Psychiatry"},{"key":"10034_CR131","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/npp.2011.65","volume":"36","author":"C Fuente-Sandoval","year":"2011","unstructured":"Fuente-Sandoval C, de la, Le\u00f3n-Ortiz P, Favila R, et al. Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis. Neuropsychopharmacology. 2011;36:1781\u201391. https:\/\/doi.org\/10.1038\/npp.2011.65.","journal-title":"Neuropsychopharmacology"},{"key":"10034_CR132","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","volume":"39","author":"A Marsman","year":"2013","unstructured":"Marsman A, van den Heuvel MP, Klomp DWJ, et al. Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies. Schizophr Bull. 2013;39:120\u20139. https:\/\/doi.org\/10.1093\/schbul\/sbr069.","journal-title":"Schizophr Bull"},{"key":"10034_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01681-4","volume":"11","author":"A Szabo","year":"2021","unstructured":"Szabo A, Akkouh IA, Vandenberghe M, et al. A human iPSC-astroglia neurodevelopmental model reveals divergent transcriptomic patterns in schizophrenia. Transl Psychiatry. 2021;11:554. https:\/\/doi.org\/10.1038\/s41398-021-01681-4.","journal-title":"Transl Psychiatry"},{"key":"10034_CR134","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S. The Dopamine Hypothesis of Schizophrenia: Version III\u2014The Final Common Pathway. Schizophr Bull. 2009;35:549\u201362. https:\/\/doi.org\/10.1093\/schbul\/sbp006.","journal-title":"Schizophr Bull"},{"key":"10034_CR135","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41537-025-00684-0","volume":"11","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Li X, Xie Y, et al. Resolving the heterogeneity of dopamine subsystems dysfunction in schizophrenia: a PET meta-analysis. Schizophrenia. 2025;11:139. https:\/\/doi.org\/10.1038\/s41537-025-00684-0.","journal-title":"Schizophrenia"},{"key":"10034_CR136","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/mp.2011.20","volume":"16","author":"O Howes","year":"2011","unstructured":"Howes O, Bose S, Turkheimer F, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry. 2011;16:885\u20136. https:\/\/doi.org\/10.1038\/mp.2011.20.","journal-title":"Mol Psychiatry"},{"key":"10034_CR137","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes OD, Kambeitz J, Kim E, et al. The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment: Meta-analysis of Imaging Studies. Arch Gen Psychiatry. 2012;69:776\u201386. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2012.169.","journal-title":"Arch Gen Psychiatry"},{"key":"10034_CR138","doi-asserted-by":"publisher","unstructured":"Mitelman SA, Buchsbaum MS, Christian BT, et al. Positive association between cerebral grey matter metabolism and dopamine D2\/D3 receptor availability in healthy and schizophrenia subjects: An 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study. World J Biol Psychiatry. 2019;1\u201315. https:\/\/doi.org\/10.1080\/15622975.2019.1671609.","DOI":"10.1080\/15622975.2019.1671609"},{"key":"10034_CR139","doi-asserted-by":"publisher","first-page":"947295","DOI":"10.3389\/fnins.2022.947295","volume":"16","author":"R Zhou","year":"2022","unstructured":"Zhou R, He M, Fan J, et al. The role of hypothalamic endoplasmic reticulum stress in schizophrenia and antipsychotic-induced weight gain: A narrative review. Front Neurosci. 2022;16:947295. https:\/\/doi.org\/10.3389\/fnins.2022.947295.","journal-title":"Front Neurosci"},{"key":"10034_CR140","doi-asserted-by":"publisher","first-page":"34981","DOI":"10.1074\/jbc.R113.506782","volume":"288","author":"M Carey","year":"2013","unstructured":"Carey M, Kehlenbrink S, Hawkins M. Evidence for central regulation of glucose metabolism. J Biol Chem. 2013;288:34981\u20138. https:\/\/doi.org\/10.1074\/jbc.R113.506782.","journal-title":"J Biol Chem"},{"key":"10034_CR141","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature12709","volume":"503","author":"MW Schwartz","year":"2013","unstructured":"Schwartz MW, Seeley RJ, Tsch\u00f6p MH, et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature. 2013;503:59\u201366. https:\/\/doi.org\/10.1038\/nature12709.","journal-title":"Nature"},{"key":"10034_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s44385-025-00036-8","volume":"2","author":"D Espinoza","year":"2025","unstructured":"Espinoza D, Seibold F, Stanley S. Central and peripheral neural circuits regulating glucose homeostasis. NPJ BioMed Innov. 2025;2:34. https:\/\/doi.org\/10.1038\/s44385-025-00036-8.","journal-title":"NPJ BioMed Innov"},{"key":"10034_CR143","doi-asserted-by":"publisher","first-page":"21913","DOI":"10.1074\/jbc.M109.087338","volume":"285","author":"CKL Lam","year":"2010","unstructured":"Lam CKL, Chari M, Su BB, et al. Activation of N-methyl-d-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production. J Biol Chem. 2010;285:21913\u201321. https:\/\/doi.org\/10.1074\/jbc.M109.087338.","journal-title":"J Biol Chem"},{"key":"10034_CR144","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1053\/j.gastro.2011.12.053","volume":"142","author":"BA Rasmussen","year":"2012","unstructured":"Rasmussen BA, Breen DM, Luo P, et al. Duodenal Activation of cAMP-Dependent Protein Kinase Induces Vagal Afferent Firing and Lowers Glucose Production in Rats. Gastroenterology. 2012;142:834\u2013e8433. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.053.","journal-title":"Gastroenterology"},{"key":"10034_CR145","doi-asserted-by":"publisher","first-page":"R492","DOI":"10.1152\/ajpregu.1995.268.2.r492","volume":"268","author":"CH Lang","year":"1995","unstructured":"Lang CH, Ajmal M, Baillie AG. Neural control of glucose uptake by skeletal muscle after central administration of NMDA. Am J Physiol Regul Integr Comp Physiol. 1995;268:R492-7. https:\/\/doi.org\/10.1152\/ajpregu.1995.268.2.r492.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10034_CR146","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.molmet.2015.06.010","volume":"4","author":"A \u00dcner","year":"2015","unstructured":"\u00dcner A, Gon\u00e7alves GHM, Li W, et al. The role of GluN2A and GluN2B NMDA receptor subunits in AgRP and POMC neurons on body weight and glucose homeostasis. Mol Metab. 2015;4:678\u201391. https:\/\/doi.org\/10.1016\/j.molmet.2015.06.010.","journal-title":"Mol Metab"},{"key":"10034_CR147","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2337\/dbi24-0002","volume":"73","author":"B Portillo","year":"2024","unstructured":"Portillo B, Hwang E, Ajwani J, et al. NMDA receptors in POMC neurons connect exercise with insulin sensitivity. Diabetes. 2024;73:1942\u201351. https:\/\/doi.org\/10.2337\/dbi24-0002.","journal-title":"Diabetes"},{"key":"10034_CR148","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.neuron.2011.11.027","volume":"73","author":"T Liu","year":"2012","unstructured":"Liu T, Kong D, Shah BP, et al. Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone. Neuron. 2012;73:511\u201322. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.027.","journal-title":"Neuron"},{"key":"10034_CR149","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.cmet.2022.09.002","volume":"34","author":"DHM Chao","year":"2022","unstructured":"Chao DHM, Kirchner MK, Pham C, et al. Hypothalamic astrocytes control systemic glucose metabolism and energy balance. Cell Metab. 2022;34:1532-1547.e6. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.002.","journal-title":"Cell Metab"},{"issue":"442","key":"10034_CR150","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar3752","volume":"10","author":"KW ter Horst","year":"2018","unstructured":"ter Horst KW, Lammers NM, Trinko R, et al. Striatal dopamine regulates systemic glucose metabolism in humans and mice. Sci Transl Med. 2018;10: https:\/\/doi.org\/10.1126\/scitranslmed.aar3752.","journal-title":"Sci Transl Med"},{"key":"10034_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79292-0","volume":"10","author":"H Ikeda","year":"2020","unstructured":"Ikeda H, Yonemochi N, Mikami R, et al. Central dopamine D2 receptors regulate plasma glucose levels in mice through autonomic nerves. Sci Rep. 2020;10:22347. https:\/\/doi.org\/10.1038\/s41598-020-79292-0.","journal-title":"Sci Rep"},{"key":"10034_CR152","doi-asserted-by":"publisher","first-page":"155696","DOI":"10.1016\/j.metabol.2023.155696","volume":"150","author":"C Diepenbroek","year":"2024","unstructured":"Diepenbroek C, Rijnsburger M, van Irsen AAS, et al. Dopamine in the nucleus accumbens shell controls systemic glucose metabolism via the lateral hypothalamus and hepatic vagal innervation in rodents. Metabolism. 2024;150:155696. https:\/\/doi.org\/10.1016\/j.metabol.2023.155696.","journal-title":"Metabolism"},{"key":"10034_CR153","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/npp.2017.112","volume":"42","author":"M Michaelides","year":"2017","unstructured":"Michaelides M, Miller ML, DiNieri JA, et al. Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2017;42:2365\u201376. https:\/\/doi.org\/10.1038\/npp.2017.112.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"10034_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175984","volume":"956","author":"H Ikeda","year":"2023","unstructured":"Ikeda H, Mikami R, Yonemochi N, Waddington JL. Regulation of plasma glucose levels by central dopamine D2 receptors is impaired in type 1 but not type 2 diabetic mouse models. Eur J Pharmacol. 2023;956:175984. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175984.","journal-title":"Eur J Pharmacol"},{"key":"10034_CR155","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.4103\/2230-8210.83058","volume":"15","author":"C Shivaprasad","year":"2011","unstructured":"Shivaprasad C, Kalra S. Bromocriptine in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2011;15:S17\u201324. https:\/\/doi.org\/10.4103\/2230-8210.83058.","journal-title":"Indian J Endocrinol Metab"},{"key":"10034_CR156","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2337\/dc09-2009","volume":"33","author":"JM Gaziano","year":"2010","unstructured":"Gaziano JM, Cincotta AH, O\u2019Connor CM, et al. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diabetes Care. 2010;33:1503\u20138. https:\/\/doi.org\/10.2337\/dc09-2009.","journal-title":"Diabetes Care"},{"key":"10034_CR157","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1038\/ncomms9543","volume":"6","author":"MA Stouffer","year":"2015","unstructured":"Stouffer MA, Woods CA, Patel JC, et al. Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun. 2015;6:8543. https:\/\/doi.org\/10.1038\/ncomms9543.","journal-title":"Nat Commun"},{"key":"10034_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00868","volume":"13","author":"F Fiory","year":"2019","unstructured":"Fiory F, Perruolo G, Cimmino I, et al. The relevance of insulin action in the dopaminergic system. Front Neurosci. 2019;13:868. https:\/\/doi.org\/10.3389\/fnins.2019.00868.","journal-title":"Front Neurosci"},{"key":"10034_CR159","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/nm1202-798","volume":"8","author":"S Obici","year":"2002","unstructured":"Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002;8:1376\u201382. https:\/\/doi.org\/10.1038\/nm1202-798.","journal-title":"Nat Med"},{"key":"10034_CR160","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1017\/S1461145713000035","volume":"16","author":"N Kumarasinghe","year":"2013","unstructured":"Kumarasinghe N, Beveridge NJ, Gardiner E, et al. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication. Int J Neuropsychopharmacol. 2013;16:1483\u2013503. https:\/\/doi.org\/10.1017\/S1461145713000035.","journal-title":"Int J Neuropsychopharmacol"},{"key":"10034_CR161","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eurpsy.2019.08.012","volume":"62","author":"D Kapogiannis","year":"2019","unstructured":"Kapogiannis D, Dobrowolny H, Tran J, et al. Insulin-signaling abnormalities in drug-na\u00efve first-episode schizophrenia: Transduction protein analyses in extracellular vesicles of putative neuronal origin. Eur Psychiatry. 2019;62:124\u20139. https:\/\/doi.org\/10.1016\/j.eurpsy.2019.08.012.","journal-title":"Eur Psychiatry"},{"key":"10034_CR162","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","volume":"22","author":"N Ben-Jonathan","year":"2001","unstructured":"Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724\u201363. https:\/\/doi.org\/10.1210\/edrv.22.6.0451.","journal-title":"Endocr Rev"},{"key":"10034_CR163","doi-asserted-by":"publisher","first-page":"T101","DOI":"10.1530\/joe-15-0213","volume":"226","author":"DR Grattan","year":"2015","unstructured":"Grattan DR. 60 years of neuroendocrinology: the hypothalamo-prolactin axis. J Endocrinol. 2015;226:T101-22. https:\/\/doi.org\/10.1530\/joe-15-0213.","journal-title":"J Endocrinol"},{"key":"10034_CR164","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","volume":"64","author":"PM Haddad","year":"2004","unstructured":"Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia. Drugs. 2004;64:2291\u2013314. https:\/\/doi.org\/10.2165\/00003495-200464200-00003.","journal-title":"Drugs"},{"key":"10034_CR165","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40263-014-0157-3","volume":"28","author":"J Peuskens","year":"2014","unstructured":"Peuskens J, Pani L, Detraux J, Hert MD. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs. 2014;28:421\u201353. https:\/\/doi.org\/10.1007\/s40263-014-0157-3.","journal-title":"CNS Drugs"},{"key":"10034_CR166","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1017\/s0033291713000226","volume":"43","author":"A Riecher-R\u00f6ssler","year":"2013","unstructured":"Riecher-R\u00f6ssler A, Rybakowski JK, Pflueger MO, et al. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychol Med. 2013;43:2571\u201382. https:\/\/doi.org\/10.1017\/s0033291713000226.","journal-title":"Psychol Med"},{"key":"10034_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1002320","volume":"13","author":"P Kirsch","year":"2022","unstructured":"Kirsch P, Kunadia J, Shah S, Agrawal N. Metabolic effects of prolactin and the role of dopamine agonists: a review. Front Endocrinol. 2022;13:1002320. https:\/\/doi.org\/10.3389\/fendo.2022.1002320.","journal-title":"Front Endocrinol"},{"key":"10034_CR168","doi-asserted-by":"publisher","first-page":"E974","DOI":"10.1152\/ajpendo.00200.2016","volume":"311","author":"GM Luque","year":"2016","unstructured":"Luque GM, Lopez-Vicchi F, Ornstein AM, et al. Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine D2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance. Am J Physiol Endocrinol Metab. 2016;311:E974\u201388. https:\/\/doi.org\/10.1152\/ajpendo.00200.2016.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10034_CR169","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1186\/1755-8794-6-s1-s17","volume":"6","author":"Y Liu","year":"2013","unstructured":"Liu Y, Li Z, Zhang M, et al. Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis. BMC Med Genomics. 2013;6:S17. https:\/\/doi.org\/10.1186\/1755-8794-6-s1-s17.","journal-title":"BMC Med Genomics"},{"key":"10034_CR170","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.07.037","volume":"34","author":"Z Li","year":"2018","unstructured":"Li Z, Chen P, Chen J, et al. Glucose and Insulin-Related Traits, Type 2 Diabetes and Risk of Schizophrenia: A Mendelian Randomization Study. EBioMedicine. 2018;34:182\u20138. https:\/\/doi.org\/10.1016\/j.ebiom.2018.07.037.","journal-title":"EBioMedicine"},{"key":"10034_CR171","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0304","author":"J Tomasik","year":"2019","unstructured":"Tomasik J, Lago SG, V\u00e1zquez-Bourgon J, et al. Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. JAMA Psychiatry. 2019. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0304.","journal-title":"JAMA Psychiatry"},{"key":"10034_CR172","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian ES, Hall D, Birnbaum MJ, et al. Convergent evidence for impaired AKT1-GSK3\u03b2 signaling in schizophrenia. Nat Genet. 2004;36:131\u20137. https:\/\/doi.org\/10.1038\/ng1296.","journal-title":"Nat Genet"},{"key":"10034_CR173","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang N-Q, Yan F, et al. Diabetes mellitus and Alzheimer\u2019s disease: GSK-3\u03b2 as a potential link. Behav Brain Res. 2018;339:57\u201365. https:\/\/doi.org\/10.1016\/j.bbr.2017.11.015.","journal-title":"Behav Brain Res"},{"key":"10034_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2012.00033","volume":"5","author":"ES Emamian","year":"2012","unstructured":"Emamian ES. AKT\/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci. 2012;5:33. https:\/\/doi.org\/10.3389\/fnmol.2012.00033.","journal-title":"Front Mol Neurosci"},{"key":"10034_CR175","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2337\/db20-0573","volume":"70","author":"L Bosque-Plata","year":"2021","unstructured":"Bosque-Plata L, Mart\u00ednez-Mart\u00ednez E, Espinoza-Camacho M\u00c1, Gragnoli C. The role of TCF7L2 in type 2 diabetes. Diabetes. 2021;70:1220\u20138. https:\/\/doi.org\/10.2337\/db20-0573.","journal-title":"Diabetes"},{"key":"10034_CR176","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biopsych.2011.01.031","volume":"70","author":"T Hansen","year":"2011","unstructured":"Hansen T, Ingason A, Djurovic S, et al. At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia. Biol Psychiatry. 2011;70:59\u201363. https:\/\/doi.org\/10.1016\/j.biopsych.2011.01.031.","journal-title":"Biol Psychiatry"},{"key":"10034_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2006.02.009","volume":"84","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Ksiezak-Reding H, Riggio S, et al. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res. 2006;84:1\u201314. https:\/\/doi.org\/10.1016\/j.schres.2006.02.009.","journal-title":"Schizophr Res"},{"key":"10034_CR178","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41386-020-0614-2","volume":"45","author":"R Chadha","year":"2020","unstructured":"Chadha R, Meador-Woodruff JH. Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in schizophrenia. Neuropsychopharmacology. 2020;45:1059\u201367. https:\/\/doi.org\/10.1038\/s41386-020-0614-2.","journal-title":"Neuropsychopharmacology"},{"key":"10034_CR179","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2021.03.007","volume":"33","author":"GF Lewis","year":"2021","unstructured":"Lewis GF, Carpentier AC, Pereira S, et al. Direct and indirect control of hepatic glucose production by insulin. Cell Metab. 2021;33:709\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.007.","journal-title":"Cell Metab"},{"key":"10034_CR180","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2006.02.009","volume":"3","author":"H Inoue","year":"2006","unstructured":"Inoue H, Ogawa W, Asakawa A, et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 2006;3:267\u201375. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.009.","journal-title":"Cell Metab"},{"key":"10034_CR181","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cmet.2007.05.004","volume":"5","author":"AC K\u00f6nner","year":"2007","unstructured":"K\u00f6nner AC, Janoschek R, Plum L, et al. Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production. Cell Metab. 2007;5:438\u201349. https:\/\/doi.org\/10.1016\/j.cmet.2007.05.004.","journal-title":"Cell Metab"},{"key":"10034_CR182","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cmet.2014.03.004","volume":"19","author":"J Qiu","year":"2014","unstructured":"Qiu J, Zhang C, Borgquist A, et al. Insulin Excites Anorexigenic Proopiomelanocortin Neurons via Activation of Canonical Transient Receptor Potential Channels. Cell Metab. 2014;19:682\u201393. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.004.","journal-title":"Cell Metab"},{"key":"10034_CR183","doi-asserted-by":"publisher","first-page":"e38704","DOI":"10.7554\/elife.38704","volume":"7","author":"GT Dodd","year":"2018","unstructured":"Dodd GT, Michael NJ, Lee-Young RS, et al. Insulin regulates POMC neuronal plasticity to control glucose metabolism. eLife. 2018;7:e38704. https:\/\/doi.org\/10.7554\/elife.38704.","journal-title":"eLife"},{"key":"10034_CR184","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.2337\/db16-1238","volume":"66","author":"AC Shin","year":"2017","unstructured":"Shin AC, Filatova N, Lindtner C, et al. Insulin receptor signaling in POMC, but not AgRP, neurons controls adipose tissue insulin action. Diabetes. 2017;66:1560\u201371. https:\/\/doi.org\/10.2337\/db16-1238.","journal-title":"Diabetes"},{"key":"10034_CR185","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12513","volume":"29","author":"GT Dodd","year":"2017","unstructured":"Dodd GT, Tiganis T. Insulin action in the brain: roles in energy and glucose homeostasis. J Neuroendocrinol. 2017;29:e12513. https:\/\/doi.org\/10.1111\/jne.12513.","journal-title":"J Neuroendocrinol"},{"key":"10034_CR186","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther. 2012;136:82\u201393. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.006.","journal-title":"Pharmacol Ther"},{"key":"10034_CR187","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrendo.2015.173","volume":"11","author":"M Heni","year":"2015","unstructured":"Heni M, Kullmann S, Preissl H, et al. Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol. 2015;11:701\u201311. https:\/\/doi.org\/10.1038\/nrendo.2015.173.","journal-title":"Nat Rev Endocrinol"},{"key":"10034_CR188","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","volume":"96","author":"S Kullmann","year":"2016","unstructured":"Kullmann S, Heni M, Hallschmid M, et al. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev. 2016;96:1169\u2013209. https:\/\/doi.org\/10.1152\/physrev.00032.2015.","journal-title":"Physiol Rev"},{"key":"10034_CR189","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2337\/db16-1380","volume":"66","author":"M Heni","year":"2017","unstructured":"Heni M, Wagner R, Kullmann S, et al. Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men. Diabetes. 2017;66:1797\u2013806. https:\/\/doi.org\/10.2337\/db16-1380.","journal-title":"Diabetes"},{"key":"10034_CR190","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1210\/jc.2007-1167","volume":"93","author":"L Nimwegen","year":"2008","unstructured":"Nimwegen L, Storosum JG, Blumer RME, et al. Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism. J Clin Endocrinol Metab. 2008;93:572\u20137. https:\/\/doi.org\/10.1210\/jc.2007-1167.","journal-title":"J Clin Endocrinol Metab"},{"key":"10034_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68950-y","author":"F Koopmans","year":"2026","unstructured":"Koopmans F, Dijkstra AA, Li W-P, et al. Human brain prefrontal cortex proteomics identifies compromised energy metabolism and neuronal function in Schizophrenia. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-68950-y.","journal-title":"Nat Commun"},{"key":"10034_CR192","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jpsychires.2023.01.005","volume":"158","author":"NK Shroitman","year":"2023","unstructured":"Shroitman NK, Yitzhaky A, Shachar DB, et al. Meta-analysis of brain samples of individuals with schizophrenia detects down-regulation of multiple ATP synthase encoding genes in both females and males. J Psychiatr Res. 2023;158:350\u20139. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.01.005.","journal-title":"J Psychiatr Res"},{"key":"10034_CR193","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.aad6469","volume":"359","author":"MJ Gandal","year":"2018","unstructured":"Gandal MJ, Haney JR, Parikshak NN, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359:693\u20137. https:\/\/doi.org\/10.1126\/science.aad6469.","journal-title":"Science"},{"key":"10034_CR194","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.410330516","volume":"33","author":"C Burkhardt","year":"1993","unstructured":"Burkhardt C, Kelly JP, Lim Y, et al. Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol. 1993;33:512\u20137. https:\/\/doi.org\/10.1002\/ana.410330516.","journal-title":"Ann Neurol"},{"key":"10034_CR195","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/jcp.0b013e318054753e","volume":"27","author":"J Casademont","year":"2007","unstructured":"Casademont J, Garrabou G, Mir\u00f3 \u00d2, et al. Neuroleptic Treatment Effect on Mitochondrial Electron Transport Chain. J Clin Psychopharmacol. 2007;27:284\u20138. https:\/\/doi.org\/10.1097\/jcp.0b013e318054753e.","journal-title":"J Clin Psychopharmacol"},{"key":"10034_CR196","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1176\/appi.ajp.2020.19111210","volume":"177","author":"JR Glausier","year":"2020","unstructured":"Glausier JR, Enwright JF, Lewis DA. Diagnosis- and cell type-specific mitochondrial functional pathway signatures in schizophrenia and bipolar disorder. Am J Psychiatry. 2020;177:1140\u201350. https:\/\/doi.org\/10.1176\/appi.ajp.2020.19111210.","journal-title":"Am J Psychiatry"},{"key":"10034_CR197","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s44192-023-00031-8","volume":"3","author":"A Kathuria","year":"2023","unstructured":"Kathuria A, Lopez-Lengowski K, McPhie D, et al. Disease-specific differences in gene expression, mitochondrial function and mitochondria-endoplasmic reticulum interactions in iPSC-derived cerebral organoids and cortical neurons in schizophrenia and bipolar disorder. Discov Ment Health. 2023;3:8. https:\/\/doi.org\/10.1007\/s44192-023-00031-8.","journal-title":"Discov Ment Health"},{"key":"10034_CR198","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1038\/s41380-019-0423-3","volume":"25","author":"P Ni","year":"2020","unstructured":"Ni P, Noh H, Park G-H, et al. iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function. Mol Psychiatry. 2020;25:2873\u201388. https:\/\/doi.org\/10.1038\/s41380-019-0423-3.","journal-title":"Mol Psychiatry"},{"key":"10034_CR199","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1017\/S1461145705005213","volume":"8","author":"C Kakiuchi","year":"2005","unstructured":"Kakiuchi C, Ishiwata M, Kametani M, et al. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol. 2005;8:515\u201322. https:\/\/doi.org\/10.1017\/S1461145705005213.","journal-title":"Int J Neuropsychopharmacol"},{"key":"10034_CR200","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.biopsych.2018.02.1175","volume":"83","author":"VF Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves VF, Cappi C, Hagen CM, et al. A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia. Biol Psychiatry. 2018;83:780\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2018.02.1175.","journal-title":"Biol Psychiatry"},{"key":"10034_CR201","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000441252","volume":"1","author":"BE Hjelm","year":"2015","unstructured":"Hjelm BE, Rollins B, Mamdani F, et al. Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. Mol Neuropsychiatry. 2015;1:201\u201319. https:\/\/doi.org\/10.1159\/000441252.","journal-title":"Mol Neuropsychiatry"},{"key":"10034_CR202","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/schbul\/sbad066","volume":"49","author":"D Kolar","year":"2023","unstructured":"Kolar D, Krajcovic B, Kleteckova L, et al. Review: Genes Involved in Mitochondrial Physiology Within 22q11.2 Deleted Region and Their Relevance to Schizophrenia. Schizophr Bull. 2023;49:1637\u201353. https:\/\/doi.org\/10.1093\/schbul\/sbad066.","journal-title":"Schizophr Bull"},{"key":"10034_CR203","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamapsychiatry.2013.2287","volume":"71","author":"F Du","year":"2014","unstructured":"Du F, Cooper AJ, Thida T, et al. In Vivo Evidence for Cerebral Bioenergetic Abnormalities in Schizophrenia Measured Using 31P Magnetization Transfer Spectroscopy. JAMA Psychiatry. 2014;71:19\u201327. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2287.","journal-title":"JAMA Psychiatry"},{"key":"10034_CR204","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.pnpbp.2006.02.003","volume":"30","author":"BN Gangadhar","year":"2006","unstructured":"Gangadhar BN, Jayakumar PN, Venkatasubramanian G, et al. Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:910\u20133. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.02.003.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10034_CR205","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0006-3223(02)01829-2","volume":"54","author":"PN Jayakumar","year":"2003","unstructured":"Jayakumar PN, Gangadhar BN, Subbakrishna DK, et al. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biol Psychiatry. 2003;54:491\u20134. https:\/\/doi.org\/10.1016\/s0006-3223(02)01829-2.","journal-title":"Biol Psychiatry"},{"key":"10034_CR206","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pscychresns.2009.10.010","volume":"181","author":"PN Jayakumar","year":"2010","unstructured":"Jayakumar PN, Gangadhar BN, Venkatasubramanian G, et al. High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia. Psychiatry Res. 2010;181:237\u201340. https:\/\/doi.org\/10.1016\/j.pscychresns.2009.10.010.","journal-title":"Psychiatry Res"},{"key":"10034_CR207","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","volume":"48","author":"JW Pettegrew","year":"1991","unstructured":"Pettegrew JW, Keshavan MS, Panchalingam K, et al. Alterations in Brain High-Energy Phosphate and Membrane Phospholipid Metabolism in First-Episode, Drug-Naive Schizophrenics: A Pilot Study of the Dorsal Prefrontal Cortex by In Vivo Phosphorus 31 Nuclear Magnetic Resonance Spectroscopy. Arch Gen Psychiatry. 1991;48:563\u20138. https:\/\/doi.org\/10.1001\/archpsyc.1991.01810300075011.","journal-title":"Arch Gen Psychiatry"},{"key":"10034_CR208","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jpsychires.2015.06.014","volume":"68","author":"C Yuksel","year":"2015","unstructured":"Yuksel C, Tegin C, O\u2019Connor L, et al. Phosphorus magnetic resonance spectroscopy studies in schizophrenia. J Psychiatr Res. 2015;68:157\u201366. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.06.014.","journal-title":"J Psychiatr Res"},{"key":"10034_CR209","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.schres.2017.02.024","volume":"187","author":"V-A Chouinard","year":"2017","unstructured":"Chouinard V-A, Kim S-Y, Valeri L, et al. Brain bioenergetics and redox state measured by 31P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizophr Res. 2017;187:11\u20136. https:\/\/doi.org\/10.1016\/j.schres.2017.02.024.","journal-title":"Schizophr Res"},{"key":"10034_CR210","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/ijms25021314","volume":"25","author":"T-H Chen","year":"2024","unstructured":"Chen T-H, Wang H-C, Chang C-J, Lee S-Y. Mitochondrial glutathione in cellular redox homeostasis and disease manifestation. Int J Mol Sci. 2024;25:1314. https:\/\/doi.org\/10.3390\/ijms25021314.","journal-title":"Int J Mol Sci"},{"key":"10034_CR211","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41380-020-0704-x","volume":"25","author":"K Dempster","year":"2020","unstructured":"Dempster K, Jeon P, MacKinley M, et al. Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate. Mol Psychiatry. 2020;25:1640\u201350. https:\/\/doi.org\/10.1038\/s41380-020-0704-x.","journal-title":"Mol Psychiatry"},{"key":"10034_CR212","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"R Gysin","year":"2007","unstructured":"Gysin R, Kraftsik R, Sandell J, et al. Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence. Proc Natl Acad Sci. 2007;104:16621\u20136. https:\/\/doi.org\/10.1073\/pnas.0706778104.","journal-title":"Proc Natl Acad Sci"},{"key":"10034_CR213","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/507566","volume":"79","author":"M Tosic","year":"2006","unstructured":"Tosic M, Ott J, Barral S, et al. Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene. Am J Hum Genet. 2006;79:586\u201392. https:\/\/doi.org\/10.1086\/507566.","journal-title":"Am J Hum Genet"},{"key":"10034_CR214","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.yjmcc.2004.11.019","volume":"38","author":"T Miki","year":"2005","unstructured":"Miki T, Seino S. Roles of KATP channels as metabolic sensors in acute metabolic changes. J Mol Cell Cardiol. 2005;38:917\u201325. https:\/\/doi.org\/10.1016\/j.yjmcc.2004.11.019.","journal-title":"J Mol Cell Cardiol"},{"key":"10034_CR215","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa031314","volume":"350","author":"KF Petersen","year":"2004","unstructured":"Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664\u201371. https:\/\/doi.org\/10.1056\/NEJMoa031314.","journal-title":"N Engl J Med"},{"key":"10034_CR216","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852\u201371. https:\/\/doi.org\/10.1016\/j.cell.2012.02.017.","journal-title":"Cell"},{"key":"10034_CR217","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1126\/science.1104343","volume":"307","author":"BB Lowell","year":"2005","unstructured":"Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384\u20137. https:\/\/doi.org\/10.1126\/science.1104343.","journal-title":"Science"},{"key":"10034_CR218","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fendo.2017.00347","volume":"8","author":"S Bhansali","year":"2017","unstructured":"Bhansali S, Bhansali A, Walia R, et al. Alterations in Mitochondrial Oxidative Stress and Mitophagy in Subjects with Prediabetes and Type 2 Diabetes Mellitus. Front Endocrinol. 2017;8:347. https:\/\/doi.org\/10.3389\/fendo.2017.00347.","journal-title":"Front Endocrinol"},{"key":"10034_CR219","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2016.02.010","volume":"164","author":"C Toda","year":"2016","unstructured":"Toda C, Kim JD, Impellizzeri D, et al. UCP2 Regulates Mitochondrial Fission and Ventromedial Nucleus Control of Glucose Responsiveness. Cell. 2016;164:872\u201383. https:\/\/doi.org\/10.1016\/j.cell.2016.02.010.","journal-title":"Cell"},{"key":"10034_CR220","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-clinpsy-081122-013201","volume":"20","author":"SS Gangadin","year":"2024","unstructured":"Gangadin SS, Enthoven AD, van Beveren NJM, et al. Immune Dysfunction in Schizophrenia Spectrum Disorders. Annu Rev Clin Psychol. 2024;20:229\u201357. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081122-013201.","journal-title":"Annu Rev Clin Psychol"},{"key":"10034_CR221","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383. https:\/\/doi.org\/10.1038\/nature16549.","journal-title":"Nature"},{"key":"10034_CR222","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","volume":"22","author":"CM Sellgren","year":"2019","unstructured":"Sellgren CM, Gracias J, Watmuff B, et al. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci. 2019;22:374\u201385. https:\/\/doi.org\/10.1038\/s41593-018-0334-7.","journal-title":"Nat Neurosci"},{"key":"10034_CR223","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","volume":"167","author":"AS Brown","year":"2010","unstructured":"Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010;167:261\u201380. https:\/\/doi.org\/10.1176\/appi.ajp.2009.09030361.","journal-title":"Am J Psychiatry"},{"key":"10034_CR224","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","volume":"154","author":"L de Witte","year":"2014","unstructured":"de Witte L, Tomasik J, Schwarz E, et al. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res. 2014;154:23\u20139. https:\/\/doi.org\/10.1016\/j.schres.2014.02.005.","journal-title":"Schizophr Res"},{"key":"10034_CR225","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553\u201365. https:\/\/doi.org\/10.1038\/nri.2016.70.","journal-title":"Nat Rev Immunol"},{"key":"10034_CR226","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","volume":"18","author":"EL Mills","year":"2017","unstructured":"Mills EL, Kelly B, O\u2019Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18:488\u201398. https:\/\/doi.org\/10.1038\/ni.3704.","journal-title":"Nat Immunol"},{"key":"10034_CR227","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2014.06.021","volume":"176","author":"P Steullet","year":"2016","unstructured":"Steullet P, Cabungcal JH, Monin A, et al. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \u201ccentral hub\u201d in schizophrenia pathophysiology? Schizophr Res. 2016;176:41\u201351. https:\/\/doi.org\/10.1016\/j.schres.2014.06.021.","journal-title":"Schizophr Res"},{"key":"10034_CR228","doi-asserted-by":"publisher","first-page":"103999","DOI":"10.1016\/j.redox.2025.103999","volume":"89","author":"DAM Dielemans","year":"2026","unstructured":"Dielemans DAM, Sutterland AL, Lutter R, et al. Alterations in lipid, redox, and energy metabolism in recent onset psychosis: a metabolomics study in non-smoking individuals and matched controls. Redox Biol. 2026;89:103999. https:\/\/doi.org\/10.1016\/j.redox.2025.103999.","journal-title":"Redox Biol"},{"key":"10034_CR229","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41398-023-02716-8","volume":"14","author":"J Lee","year":"2024","unstructured":"Lee J, Xue X, Au E, et al. Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures. Transl Psychiatry. 2024;14:19. https:\/\/doi.org\/10.1038\/s41398-023-02716-8.","journal-title":"Transl Psychiatry"},{"key":"10034_CR230","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457\u201361. https:\/\/doi.org\/10.1126\/science.1103160.","journal-title":"Science"},{"key":"10034_CR231","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2008.07.043","volume":"135","author":"X Zhang","year":"2008","unstructured":"Zhang X, Zhang G, Zhang H, et al. Hypothalamic IKK\u03b2\/NF-\u03baB and ER stress link overnutrition to energy imbalance and obesity. Cell. 2008;135:61\u201373. https:\/\/doi.org\/10.1016\/j.cell.2008.07.043.","journal-title":"Cell"},{"key":"10034_CR232","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137. https:\/\/doi.org\/10.1038\/nature05485.","journal-title":"Nature"},{"key":"10034_CR233","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cmet.2019.05.021","volume":"30","author":"D Cai","year":"2019","unstructured":"Cai D, Khor S. Hypothalamic microinflammation paradigm in aging and metabolic diseases. Cell Metab. 2019;30:19\u201335. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.021.","journal-title":"Cell Metab"},{"key":"10034_CR234","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s12276-021-00560-8","volume":"53","author":"KR Bhattarai","year":"2021","unstructured":"Bhattarai KR, Riaz TA, Kim H-R, Chae H-J. The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling. Exp Mol Med. 2021;53:151\u201367. https:\/\/doi.org\/10.1038\/s12276-021-00560-8.","journal-title":"Exp Mol Med"},{"key":"10034_CR235","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21:421\u201338. https:\/\/doi.org\/10.1038\/s41580-020-0250-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10034_CR236","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033928","volume":"11","author":"PG Needham","year":"2019","unstructured":"Needham PG, Guerriero CJ, Brodsky JL. Chaperoning endoplasmic reticulum-associated degradation (ERAD) and protein conformational diseases. Cold Spring Harb Perspect Biol. 2019;11:a033928. https:\/\/doi.org\/10.1101\/cshperspect.a033928.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10034_CR237","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fncel.2014.00213","volume":"8","author":"N Chaudhari","year":"2014","unstructured":"Chaudhari N, Talwar P, Parimisetty A, et al. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci. 2014;8:213. https:\/\/doi.org\/10.3389\/fncel.2014.00213.","journal-title":"Front Cell Neurosci"},{"key":"10034_CR238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.EJ15-0540","volume":"63","author":"H Inoue","year":"2016","unstructured":"Inoue H. Central insulin-mediated regulation of hepatic glucose production [Review]. Endocr J. 2016;63:1\u20137. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0540.","journal-title":"Endocr J"},{"key":"10034_CR239","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1210\/en.2004-1520","volume":"146","author":"CT De Souza","year":"2005","unstructured":"De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146:4192\u20139. https:\/\/doi.org\/10.1210\/en.2004-1520.","journal-title":"Endocrinology"},{"key":"10034_CR240","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.cmet.2017.04.002","volume":"25","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Reichel JM, Han C, et al. Astrocytic process plasticity and IKK\u03b2\/NF-\u03baB in central control of blood glucose, blood pressure, and body weight. Cell Metab. 2017;25:1091-1102.e4. https:\/\/doi.org\/10.1016\/j.cmet.2017.04.002.","journal-title":"Cell Metab"},{"key":"10034_CR241","doi-asserted-by":"publisher","DOI":"10.3390\/genes12020237","volume":"12","author":"MR Rahman","year":"2021","unstructured":"Rahman MR, Islam T, Nicoletti F, et al. Identification of common pathogenetic processes between schizophrenia and diabetes mellitus by systems biology analysis. Genes. 2021;12:237. https:\/\/doi.org\/10.3390\/genes12020237.","journal-title":"Genes"},{"key":"10034_CR242","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1460-9568.2005.04340.x","volume":"22","author":"T Abe","year":"2005","unstructured":"Abe T, Matsumura S, Katano T, et al. Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci. 2005;22:1445\u201354. https:\/\/doi.org\/10.1111\/j.1460-9568.2005.04340.x.","journal-title":"Eur J Neurosci"},{"key":"10034_CR243","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1742-4658.2011.08391.x","volume":"279","author":"CH Trepanier","year":"2012","unstructured":"Trepanier CH, Jackson MF, MacDonald JF. Regulation of NMDA receptors by the tyrosine kinase Fyn. FEBS J. 2012;279:12\u20139. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08391.x.","journal-title":"FEBS J"},{"key":"10034_CR244","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jnr.23713","volume":"94","author":"L-M Mao","year":"2016","unstructured":"Mao L-M, Wang JQ. Dopamine D2 receptors are involved in the regulation of Fyn and metabotropic glutamate receptor 5 phosphorylation in the rat striatum in vivo. J Neurosci Res. 2016;94:329\u201338. https:\/\/doi.org\/10.1002\/jnr.23713.","journal-title":"J Neurosci Res"},{"key":"10034_CR245","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s12031-017-0894-0","volume":"61","author":"L-M Mao","year":"2017","unstructured":"Mao L-M, Wang JQ. Antagonism of dopamine D2 receptors alters phosphorylation of Fyn in the rat medial prefrontal cortex. J Mol Neurosci. 2017;61:524\u201330. https:\/\/doi.org\/10.1007\/s12031-017-0894-0.","journal-title":"J Mol Neurosci"},{"key":"10034_CR246","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10519-018-9893-3","volume":"48","author":"D Curtis","year":"2018","unstructured":"Curtis D, Coelewij L, Liu S-H, et al. Weighted burden analysis of exome-sequenced case-control sample implicates synaptic genes in schizophrenia aetiology. Behav Genet. 2018;48:198\u2013208. https:\/\/doi.org\/10.1007\/s10519-018-9893-3.","journal-title":"Behav Genet"},{"key":"10034_CR247","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/ng.3973","volume":"49","author":"Z Li","year":"2017","unstructured":"Li Z, Chen J, Yu H, et al. Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. Nat Genet. 2017;49:1576\u201383. https:\/\/doi.org\/10.1038\/ng.3973.","journal-title":"Nat Genet"},{"key":"10034_CR248","doi-asserted-by":"publisher","first-page":"10583","DOI":"10.1074\/jbc.271.18.10583","volume":"271","author":"XJ Sun","year":"1996","unstructured":"Sun XJ, Pons S, Asano T, et al. The Fyn Tyrosine Kinase Binds Irs-1 and Forms a Distinct Signaling Complex during Insulin Stimulation (\u2217). J Biol Chem. 1996;271:10583\u20137. https:\/\/doi.org\/10.1074\/jbc.271.18.10583.","journal-title":"J Biol Chem"},{"key":"10034_CR249","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47080623","volume":"47","author":"R Xiao","year":"2025","unstructured":"Xiao R, Shen C, Shen W, et al. Fyn kinase: a potential target in glucolipid metabolism and diabetes mellitus. Curr Issues Mol Biol. 2025;47:623. https:\/\/doi.org\/10.3390\/cimb47080623.","journal-title":"Curr Issues Mol Biol"},{"key":"10034_CR250","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cmet.2007.04.005","volume":"5","author":"CC Bastie","year":"2007","unstructured":"Bastie CC, Zong H, Xu J, et al. Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the Src kinase family member fyn. Cell Metab. 2007;5:371\u201381. https:\/\/doi.org\/10.1016\/j.cmet.2007.04.005.","journal-title":"Cell Metab"},{"key":"10034_CR251","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2009.12.010","volume":"11","author":"E Yamada","year":"2010","unstructured":"Yamada E, Pessin JE, Kurland IJ, et al. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metab. 2010;11:113\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2009.12.010.","journal-title":"Cell Metab"},{"key":"10034_CR252","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003149","volume":"5","author":"Y-J Kim","year":"2012","unstructured":"Kim Y-J, Sano T, Nabetani T, et al. GPRC5B activates obesity-associated inflammatory signaling in adipocytes. Sci Signal. 2012;5:ra85. https:\/\/doi.org\/10.1126\/scisignal.2003149.","journal-title":"Sci Signal"},{"key":"10034_CR253","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/db12-0920","volume":"62","author":"T-W Lee","year":"2013","unstructured":"Lee T-W, Kwon H, Zong H, et al. Fyn deficiency promotes a preferential increase in subcutaneous adipose tissue mass and decreased visceral adipose tissue inflammation. Diabetes. 2013;62:1537\u201346. https:\/\/doi.org\/10.2337\/db12-0920.","journal-title":"Diabetes"},{"key":"10034_CR254","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081866","volume":"8","author":"Y Yang","year":"2013","unstructured":"Yang Y, Tarabra E, Yang G-S, et al. Alteration of de novo glucose production contributes to fasting hypoglycaemia in fyn deficient mice. PLoS ONE. 2013;8:e81866. https:\/\/doi.org\/10.1371\/journal.pone.0081866.","journal-title":"PLoS ONE"},{"key":"10034_CR255","doi-asserted-by":"publisher","first-page":"e3000445","DOI":"10.1371\/journal.pbio.3000445","volume":"17","author":"Y Schwarz","year":"2019","unstructured":"Schwarz Y, Oleinikov K, Schindeldecker B, et al. TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses. PLoS Biol. 2019;17:e3000445. https:\/\/doi.org\/10.1371\/journal.pbio.3000445.","journal-title":"PLoS Biol"},{"key":"10034_CR256","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.celrep.2016.12.072","volume":"18","author":"Y Gao","year":"2017","unstructured":"Gao Y, Yao T, Deng Z, et al. TrpC5 Mediates Acute Leptin and Serotonin Effects via Pomc Neurons. Cell Rep. 2017;18:583\u201392. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.072.","journal-title":"Cell Rep"},{"key":"10034_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102078","volume":"91","author":"R Asgari","year":"2025","unstructured":"Asgari R, Caceres-Valdiviezo M, Wu S, et al. Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system. Mol Metab. 2025;91:102078. https:\/\/doi.org\/10.1016\/j.molmet.2024.102078.","journal-title":"Mol Metab"},{"key":"10034_CR258","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.biopsych.2013.12.019","volume":"76","author":"L El-Hassar","year":"2014","unstructured":"El-Hassar L, Simen AA, Duque A, et al. Disrupted in schizophrenia 1 modulates medial prefrontal cortex pyramidal neuron activity through cAMP regulation of transient receptor potential C and small-conductance K+ channels. Biol Psychiatry. 2014;76:476\u201385. https:\/\/doi.org\/10.1016\/j.biopsych.2013.12.019.","journal-title":"Biol Psychiatry"},{"key":"10034_CR259","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1046\/j.1471-4159.2003.01806.x","volume":"85","author":"OA Sergeeva","year":"2003","unstructured":"Sergeeva OA, Korotkova TM, Scherer A, et al. Co\u2010expression of non\u2010selective cation channels of the transient receptor potential canonical family in central aminergic neurones. J Neurochem. 2003;85:1547\u201352. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01806.x.","journal-title":"J Neurochem"},{"key":"10034_CR260","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41562-023-01792-6","volume":"8","author":"S-D Chen","year":"2024","unstructured":"Chen S-D, You J, Zhang W, et al. The genetic architecture of the human hypothalamus and its involvement in neuropsychiatric behaviours and disorders. Nat Hum Behav. 2024;8:779\u201393. https:\/\/doi.org\/10.1038\/s41562-023-01792-6.","journal-title":"Nat Hum Behav"},{"key":"10034_CR261","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2017.10.035","volume":"641","author":"T Sundararajan","year":"2018","unstructured":"Sundararajan T, Manzardo AM, Butler MG. Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases. Gene. 2018;641:25\u201334. https:\/\/doi.org\/10.1016\/j.gene.2017.10.035.","journal-title":"Gene"},{"key":"10034_CR262","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41593-024-01834-w","volume":"28","author":"LE Duncan","year":"2025","unstructured":"Duncan LE, Li T, Salem M, et al. Mapping the cellular etiology of schizophrenia and complex brain phenotypes. Nat Neurosci. 2025;28:248\u201358. https:\/\/doi.org\/10.1038\/s41593-024-01834-w.","journal-title":"Nat Neurosci"},{"key":"10034_CR263","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41588-018-0129-5","volume":"50","author":"NG Skene","year":"2018","unstructured":"Skene NG, Bryois J, Bakken TE, et al. Genetic identification of brain cell types underlying schizophrenia. Nat Genet. 2018;50:825\u201333. https:\/\/doi.org\/10.1038\/s41588-018-0129-5.","journal-title":"Nat Genet"},{"key":"10034_CR264","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/hmg\/ddx076","volume":"26","author":"H Eachus","year":"2017","unstructured":"Eachus H, Bright C, Cunliffe VT, et al. Disrupted-in-Schizophrenia-1 is essential for normal hypothalamic-pituitary-interrenal (HPI) axis function. Hum Mol Genet. 2017;26:1992\u20132005. https:\/\/doi.org\/10.1093\/hmg\/ddx076.","journal-title":"Hum Mol Genet"},{"key":"10034_CR265","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.biopsych.2006.06.027","volume":"61","author":"JM Goldstein","year":"2007","unstructured":"Goldstein JM, Seidman LJ, Makris N, et al. Hypothalamic Abnormalities in Schizophrenia: Sex Effects and Genetic Vulnerability. Biol Psychiatry. 2007;61:935\u201345. https:\/\/doi.org\/10.1016\/j.biopsych.2006.06.027.","journal-title":"Biol Psychiatry"},{"key":"10034_CR266","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.euroneuro.2007.12.004","volume":"18","author":"PCMP Koolschijn","year":"2008","unstructured":"Koolschijn PCMP, Haren N, Pol HEH, Kahn RS. Hypothalamus volume in twin pairs discordant for schizophrenia. Eur Neuropsychopharmacol. 2008;18:312\u20135. https:\/\/doi.org\/10.1016\/j.euroneuro.2007.12.004.","journal-title":"Eur Neuropsychopharmacol"},{"key":"10034_CR267","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1017\/s1461145711000794","volume":"15","author":"A Klomp","year":"2012","unstructured":"Klomp A, Koolschijn PCMP, Pol HEH, et al. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. Int J Neuropsychopharmacol. 2012;15:281\u20138. https:\/\/doi.org\/10.1017\/s1461145711000794.","journal-title":"Int J Neuropsychopharmacol"},{"key":"10034_CR268","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pscychresns.2012.10.006","volume":"204","author":"S Tognin","year":"2012","unstructured":"Tognin S, Rambaldelli G, Perlini C, et al. Enlarged hypothalamic volumes in schizophrenia. Psychiatry Res Neuroimaging. 2012;204:75\u201381. https:\/\/doi.org\/10.1016\/j.pscychresns.2012.10.006.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10034_CR269","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/schbul\/sbad176","volume":"50","author":"A Ruggeri","year":"2024","unstructured":"Ruggeri A, Nerland S, M\u00f8rch-Johnsen L, et al. Hypothalamic Subunit Volumes in Schizophrenia and Bipolar Spectrum Disorders. Schizophr Bull. 2024;50:533\u201344. https:\/\/doi.org\/10.1093\/schbul\/sbad176.","journal-title":"Schizophr Bull"},{"key":"10034_CR270","doi-asserted-by":"publisher","first-page":"111127","DOI":"10.1016\/j.pnpbp.2024.111127","volume":"135","author":"X Li","year":"2024","unstructured":"Li X, Zeng J, Liu N, et al. Progressive alterations of resting-state hypothalamic dysconnectivity in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2024;135:111127. https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111127.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10034_CR271","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/b978-0-12-819973-2.00008-3","volume":"182","author":"H-G Bernstein","year":"2021","unstructured":"Bernstein H-G, Keilhoff G, Steiner J. Chap. 8 The implications of hypothalamic abnormalities for schizophrenia. Handb Clin Neurol. 2021;182:107\u201320. https:\/\/doi.org\/10.1016\/b978-0-12-819973-2.00008-3.","journal-title":"Handb Clin Neurol"},{"key":"10034_CR272","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1359786810385491","volume":"24","author":"AJ Bradley","year":"2010","unstructured":"Bradley AJ, Dinan TG. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol (Oxf). 2010;24:91\u2013118. https:\/\/doi.org\/10.1177\/1359786810385491.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"10034_CR273","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.jpsychires.2012.07.011","volume":"46","author":"G Sugranyes","year":"2012","unstructured":"Sugranyes G, Thompson JL, Corcoran CM. HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis. J Psychiatr Res. 2012;46:1389\u201393. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.07.011.","journal-title":"J Psychiatr Res"},{"key":"10034_CR274","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.4","volume":"48","author":"E Roh","year":"2016","unstructured":"Roh E, Song DK, Kim M-S. Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med. 2016;48:e216\u2013e216. https:\/\/doi.org\/10.1038\/emm.2016.4.","journal-title":"Exp Mol Med"},{"key":"10034_CR275","doi-asserted-by":"publisher","first-page":"C141","DOI":"10.1152\/ajpcell.00533.2022","volume":"325","author":"S Pan","year":"2023","unstructured":"Pan S, Worker CJ, Earley YF. The hypothalamus as a key regulator of glucose homeostasis: emerging roles of the brain renin-angiotensin system. Am J Physiol-Cell Physiol. 2023;325:C141\u201354. https:\/\/doi.org\/10.1152\/ajpcell.00533.2022.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"10034_CR276","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.celrep.2019.12.009","volume":"30","author":"T Kasai","year":"2020","unstructured":"Kasai T, Suga H, Sakakibara M, et al. Hypothalamic Contribution to Pituitary Functions Is Recapitulated In Vitro Using 3D-Cultured Human iPS Cells. Cell Rep. 2020;30:18\u2013e245. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.009.","journal-title":"Cell Rep"},{"key":"10034_CR277","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.stem.2021.04.006","volume":"28","author":"W-K Huang","year":"2021","unstructured":"Huang W-K, Wong SZH, Pather SR, et al. Generation of hypothalamic arcuate organoids from human induced pluripotent stem cells. Cell Stem Cell. 2021;28:1657\u2013e167010. https:\/\/doi.org\/10.1016\/j.stem.2021.04.006.","journal-title":"Cell Stem Cell"},{"key":"10034_CR278","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1215807","volume":"14","author":"V Battini","year":"2023","unstructured":"Battini V, Cirnigliaro G, Leuzzi R, et al. The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression. Front Psychiatry. 2023;14:1215807. https:\/\/doi.org\/10.3389\/fpsyt.2023.1215807.","journal-title":"Front Psychiatry"},{"key":"10034_CR279","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12916-025-04218-4","volume":"23","author":"J Cai","year":"2025","unstructured":"Cai J, Xiao J, Long Y, et al. Metformin-improved cognitive impairment in patients with schizophrenia is correlated with activation of tricarboxylic acid cycle and restored functional connectivity of hippocampus. BMC Med. 2025;23:349. https:\/\/doi.org\/10.1186\/s12916-025-04218-4.","journal-title":"BMC Med"},{"key":"10034_CR280","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41398-023-02616-x","volume":"13","author":"T Shao","year":"2023","unstructured":"Shao T, Huang J, Zhao Y, et al. Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex. Transl Psychiatry. 2023;13:315. https:\/\/doi.org\/10.1038\/s41398-023-02616-x.","journal-title":"Transl Psychiatry"},{"key":"10034_CR281","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/jamapsychiatry.2025.2332","volume":"82","author":"AA Ganeshalingam","year":"2025","unstructured":"Ganeshalingam AA, Uhrenholt N, Arnfred S, et al. Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial. JAMA Psychiatry. 2025;82:1065\u201374. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.2332.","journal-title":"JAMA Psychiatry"},{"key":"10034_CR282","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s44220-025-00390-x","volume":"3","author":"RD Giorgi","year":"2025","unstructured":"Giorgi RD, Ghenciulescu A, Dziwisz O, et al. An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders. Nat Ment Health. 2025;3:354\u201373. https:\/\/doi.org\/10.1038\/s44220-025-00390-x.","journal-title":"Nat Ment Health"},{"key":"10034_CR283","doi-asserted-by":"publisher","unstructured":"Mukherjee S, Skrede S, Fern\u00f8 J. The hypothalamus as a therapeutic target: Towards novel approaches for managing antipsychotic-induced weight gain. Rev Endocr Metab Disord. 2025;1\u201315. https:\/\/doi.org\/10.1007\/s11154-025-10009-2.","DOI":"10.1007\/s11154-025-10009-2"},{"key":"10034_CR284","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf150","volume":"9","author":"K M\u00fcller Alves","year":"2025","unstructured":"M\u00fcller Alves K, Teixeira da Silva M, Kramer CK, Viana LV. GLP-1R agonists for weight loss in psychiatric disorders: a systematic review and meta-analysis. J Endocr Soc. 2025;9:bvaf150. https:\/\/doi.org\/10.1210\/jendso\/bvaf150.","journal-title":"J Endocr Soc"},{"key":"10034_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110527","volume":"278","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty S, Shankaranarayana Rao BS, Tripathi SJ. The neuroprotective effects of N-acetylcysteine in psychiatric and neurodegenerative disorders: from modulation of glutamatergic transmission to restoration of synaptic plasticity. Neuropharmacology. 2025;278:110527. https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110527.","journal-title":"Neuropharmacology"},{"key":"10034_CR286","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/1028415X.2018.1478766","volume":"23","author":"COB Yolland","year":"2020","unstructured":"Yolland COB, Phillipou A, Castle DJ, et al. Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review. Nutr Neurosci. 2020;23:139\u201348. https:\/\/doi.org\/10.1080\/1028415X.2018.1478766.","journal-title":"Nutr Neurosci"},{"key":"10034_CR287","doi-asserted-by":"publisher","first-page":"1603722","DOI":"10.3389\/fphar.2025.1603722","volume":"16","author":"C Chaves","year":"2025","unstructured":"Chaves C, Fabe J, Gomes FA, et al. Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives. Front Pharmacol. 2025;16:1603722. https:\/\/doi.org\/10.3389\/fphar.2025.1603722.","journal-title":"Front Pharmacol"},{"key":"10034_CR288","doi-asserted-by":"publisher","first-page":"115866","DOI":"10.1016\/j.psychres.2024.115866","volume":"335","author":"S Sethi","year":"2024","unstructured":"Sethi S, Wakeham D, Ketter T, et al. Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial. Psychiatry Res. 2024;335:115866. https:\/\/doi.org\/10.1016\/j.psychres.2024.115866.","journal-title":"Psychiatry Res"},{"key":"10034_CR289","doi-asserted-by":"publisher","first-page":"e0325489","DOI":"10.1371\/journal.pone.0325489","volume":"20","author":"K Zemmour","year":"2025","unstructured":"Zemmour K, Samson G-O, Fortier M, et al. Brain glucose and ketone metabolism in first-episode psychosis: Neuroimaging and brain metabolism before and after antipsychotic treatment: The protocol for the CAST-ATP study. PLoS ONE. 2025;20:e0325489. https:\/\/doi.org\/10.1371\/journal.pone.0325489.","journal-title":"PLoS ONE"},{"key":"10034_CR290","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.1128294","volume":"313","author":"U Ozcan","year":"2006","unstructured":"Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313:1137\u201340. https:\/\/doi.org\/10.1126\/science.1128294.","journal-title":"Science"},{"key":"10034_CR291","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-physiol-022724-104836","volume":"87","author":"DJ Bishop","year":"2025","unstructured":"Bishop DJ, Lee M-C, Picard M. Exercise as mitochondrial medicine: how does the exercise prescription affect mitochondrial adaptations to training? Annu Rev Physiol. 2025;87:107\u201329. https:\/\/doi.org\/10.1146\/annurev-physiol-022724-104836.","journal-title":"Annu Rev Physiol"},{"key":"10034_CR292","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1249\/MSS.0000000000000605","volume":"47","author":"C Porter","year":"2015","unstructured":"Porter C, Reidy PT, Bhattarai N, et al. Resistance exercise training alters mitochondrial function in human skeletal muscle. Med Sci Sports Exerc. 2015;47:1922\u201331. https:\/\/doi.org\/10.1249\/MSS.0000000000000605.","journal-title":"Med Sci Sports Exerc"},{"key":"10034_CR293","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.cmet.2018.04.010","volume":"27","author":"EF Sutton","year":"2018","unstructured":"Sutton EF, Beyl R, Early KS, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018;27:1212\u2013e12213. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.010.","journal-title":"Cell Metab"},{"key":"10034_CR294","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s44220-025-00422-6","volume":"3","author":"AC Andreazza","year":"2025","unstructured":"Andreazza AC, Barros LF, Behnke A, et al. Brain and body energy metabolism and potential for treatment of psychiatric disorders. Nat Ment Health. 2025;3:763\u201371. https:\/\/doi.org\/10.1038\/s44220-025-00422-6.","journal-title":"Nat Ment Health"},{"key":"10034_CR295","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41537-025-00566-5","volume":"11","author":"S Gangachannaiah","year":"2025","unstructured":"Gangachannaiah S, Shenoy S, Upadhya D, et al. Potential of extracellular vesicle cargo as molecular signals in Schizophrenia: a scoping review. Schizophrenia. 2025;11:17. https:\/\/doi.org\/10.1038\/s41537-025-00566-5.","journal-title":"Schizophrenia"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10034-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:45:40Z","timestamp":1780897540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10034-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":295,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10034"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10034-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"M.K.H. has served as a consultant for Alkermes, Merck, and Eli Lilly. Previously, a portion of S.P.\u2019s salary at the Centre for Addiction and Mental Health came from a grant awarded by Merck Canada Inc. S.M.A. has served as a consultant for HLS Therapeutics, Boehringer Ingelheim Canada, and Bristol Myers Squibb.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}